7.2
CiteScore
3.7
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
ABUNDANCE ESTIMATION IN AN ARID ENVIRONMENT
Case Study
Correspondence
Corrigendum
Editorial
Full Length Article
Invited review
Letter to the Editor
Original Article
Retraction notice
REVIEW
Review Article
SHORT COMMUNICATION
Short review
7.2
CiteScore
3.7
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
ABUNDANCE ESTIMATION IN AN ARID ENVIRONMENT
Case Study
Correspondence
Corrigendum
Editorial
Full Length Article
Invited review
Letter to the Editor
Original Article
Retraction notice
REVIEW
Review Article
SHORT COMMUNICATION
Short review
View/Download PDF

Translate this page into:

Original article
10 2021
:33;
101529
doi:
10.1016/j.jksus.2021.101529

In-silico analysis of phylogenetic relationship and potentially damaging nsSNPs in human SLC2A2 gene

Department of Zoology, The Women University Multan, Multan, Pakistan
Department of Biological Sciences, International Islamic University, Islamabad, Pakistan
Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia

⁎Corresponding author. mamoona.noreen@gmail.com (Mamoona Noreen)

Disclaimer:
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.

Peer review under responsibility of King Saud University.

Abstract

Transport of glucose across the eukaryotic cell membranes is carried out by members of the glucose transporter (GLUT) family which is mainly divided into three classes (I, II and III) on the basis of phylogenetic relationship. In humans, one member of Class I called GLUT2 is encoded by solute carrier family 2, facilitated glucose transporter member 2 (SLC2A2) gene located on third chromosome. Protein mediated glucose movement across cell membranes is made possible through GLUT2 that is a trans-membrane carrier protein. It regulates the entry of glucose and secretion of insulin in the pancreatic cell. It has three isoforms and the longest isoform consists of 524 amino acid. There are 13 extracellular, 12 transmembrane and 5 cytoplasmic domains in human GLUT2. The risk of Fanconi-Bickel syndrome (FBS), diabetes, breast cancer (BC) and Alzheimer disease (AD) is associated with improper functioning of GLUT2. The most frequent form of genetic changes is single nucleotide polymorphism (SNPs). Non synonymous SNPs (nsSNPs) can result in alterations of amino acids and subsequent changes in phenotype. In this study, in-silico analysis was done to find phylogenetic relationship of human GLUT2 protein and possible deleterious effect of nsSNPs of its coding region. Clustal Omega was used to make phylogenetic tree. SIFT, PolyPhen, PROVEAN and SNPeffect were used to predict deleterious or tolerated SNPs. 167 nsSNPs were predicted to be damaging by SIFT, 65 to be possibly damaging and 77 to be probably damaging by PolyPhen. PROVEAN predicted 162 nsSNPs to be neutral and 138 to be deleterious. 101 SNPs were found to be damaging by three algorithms; SIFT, PolyPhen and PROVEAN.

Keywords

GLUT2
SLC2A2 gene
In silico analysis
nsSNP
Phylogenetic analysis
1

1 Introduction

Glucose is a major energy source and is an important substrate for both protein and lipid synthesis in mammalian cells. Through glycolysis and the citric acid cycle it supplies energy in the form of adenosine tri phosphate (ATP). In the form of nicotinamide adenine dinucleotide phosphate (NADPH), it provides reducing power through the pentose phosphate shunt. Glucose plays a vital role in retaining cellular homeostasis and metabolic functions. For generating ATP molecules, every vertebrate cell depends on the continuous delivery of glucose (Cant et al., 2002). Glucose transport across the plasma membranes is done by two distinct processes depending on the type of cells and tissues. First is facilitative transport that is interceded by a group of facilitative glucose transporters (GLUT) (Mueckler, 1994; Joost and Thorens, 2001) and the other is sodium dependent transport that is interceded by the Na+/glucose linked transporters (SGLT) (Wright, 2001).

GLUTs are proteins of ∼500 amino acids and are estimated to have 12 transmembrane-spanning alpha helices and a single N-linked oligosaccharide. Based on the phylogenetic analysis and sequence similarities 14 members of GLUT family can be divided into three different classes; Class I, II and III (Thorens and Mueckler, 2010; Joost et al., 2002). Class I includes GLUT 1, 2, 3, 4 and 14, class II includes GLUT 5, 7, 9 and 11 while GLUT 6, 8, 10, 12 and 13 are classified as class III (Manolescu et al., 2007). In humans the solute carrier family 2 (facilitated glucose transporter), member 2 (SLC2A2) gene is located on q26.2 of chromosome 3 (Fig. 1) which encodes GLUT2 protein. There are three isoforms of GLUT2; NP_000331.1, NP_001265587.1 and NP_001265588.1.

Location of GLUT2 on human chromosome. Arrow head shows that GLUT2 occupies 3q26.2 on third human chromosome. (https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLC2A2).
Fig. 1
Location of GLUT2 on human chromosome. Arrow head shows that GLUT2 occupies 3q26.2 on third human chromosome. (https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLC2A2).

The GLUT2 is a transmembrane carrier protein and it permits protein facilitated glucose movement across cell membranes. GLUT2 is involved in discharge of absorbed or reabsorbed glucose and is mainly expressed in the kidney and intestinal absorptive epithelial cells of basolateral membrane (Wright et al., 2003; Kellett and Brot-Laroche, 2005). GLUT2 is also present in the liver, brain and pancreas. It serves as major glucose transporter for the islet cells. As GLUT2 is a high capacity transporter, the concentration of glucose in the cell is directly proportional to the extracellular level of glucose. Enhanced level of intracellular glucose is supposed to increase the ATP/ADP ratio which will shut ATP sensitive potassium channels, depolarize the cells and secrete insulin (Schuit et al., 2001).

In hepatocytes, as a result of gluconeogenesis, GLUT2 supports the uptake of glucose into the blood. It also yields insulin secretion as glucose-sensing functions in the pancreatic β-cell and hypothalamus as low level of glucose stimulated insulin was described in GLUT2 knockout mice (Guillam et al., 1997; Burcelin et al., 2001; Bady et al., 2006). In β-cells of pancreatic islets and hepatocytes, the major glucose transporter is GLUT2. In both cell types, GLUT2 helps the facilitated diffusion of glucose across the cell membranes, and then intracellular glucose metabolism is initiated by the glucose-phosphorylating enzyme, hexokinase IV or glucokinase. In the β-cells, the rate of glucose metabolism controls insulin secretion, whereas in the liver, glucose metabolism and transport are essential to subsequent glycogen synthesis and gluconeogenesis (Meglasson et al., 1986; Thorens et al., 1988).

Fanconi Bickel Syndrome (FBS) is an autosomal recessive disease of glucose metabolism characterized by accumulation of hepatorenal glycogen, Fanconi nephropathy, and impaired use of glucose and galactose (Fanconi, 1949; Santer et al., 1998). The risk of diabetes has been found to be associated with SNPs of SLC2A2 gene in some (Barroso et al., 2003; Alcolado and Alcolado, 1991) but not in other studies (Matsutani et al.,1990). Globally, breast cancer (BC) is the most frequent cancer among women (Ilahi et al., 2016; Noreen et al., 2015a, 2015b). One way to stimulate growth of cancer cells may be fructose metabolism and the expression of GLUT5 and GLUT2 in BC is elevated and helpful in fructose metabolism (Godoy et al., 2006). The increased level of GLUT2 was observed in patients of Alzheimer disease (AD) (Liu et al., 2008).

Diseases susceptibility and development is affected by presence of genetic variations, one very common type of which is single nucleotide polymorphism or SNPs. In DNA, SNPs are found in both exonic and intronic regions (Noreen et al. 2012). Non synonymous SNPs (nsSNPs) residing in exonic region of protein involve amino acid substitution which can result in alteration of structure and functioning of the protein. Thus nsSNPs can play more significant role in diseases development. In this study we predicted the structural and functional effect of potential genetic variations of human SLC2A2 gene by using some sequence and structural homology based algorithms.

2

2 Materials and methods

2.1

2.1 Dataset compilation

National centre for biological information; NCBI (http://www.ncbi. nlm.nih.gov) was accessed. Protein and nucleotide sequences were acquired in FASTA format. Public SNP database named as dbSNP (http://www. ncbi.nlm.nih.gov/SNP), Gene Cards (http://www.genecards.org/) and UniProt (http://www.uniprot.org) were searched to assemble information related to longest isoform of GLUT2 regarding protein sequence. (GLUT2 gene ID: 6514 SNPs NCBI Reference Sequence: NP_000331). The coding region nsSNPs were screened and were subjected to further computational analysis.

2.2

2.2 Phylogenetic analysis

To carry out phylogenetic analysis, protein sequence of human GLUT2 (GenBank Accession Number: NP 000331.1) along other 9 species of Hominidae family; Gorilla gorillagorilla (XP_004038053.1), Pongo abelli (XP_002814322.1), Rhinopithecus roxellana (XP_010359570.1), Microcebus murinus (XP_012591846.1), Bos taurus (DAA33241.1), Myotis brandtii (XP_005886638.1), Neomonachus schauinsland (XP_021558267.1), Galeopterus variegates (XP_008586350.1) and Ailuropoda melanoleuca (XP_002920886.1) were retrieved from the NCBI. Protein sequence in FASTA format of all 10 species was obtained and saved. Protein sequence alignment was performed using Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/). In Clustal Omega, output format “ClustalW with charater counts” was chosen and option of phylogenetic tree was clicked.

2.3

2.3 Membrane topology

The number of machine learning algorithms wre used to align the set of protein sequences and clustering of topological data. These approaches or algorithms are transmembrane helices prediction (PHDhtm) (Rost et al. 1996), statistical algorithm TMAP (Persson and Argos 1994) and Hidden Markov models (HMMs) (HMMTOP (Tusnady and Simon, 1998, 2001); TMHMM (Sonnhammer et al., 1998; Krogh et al., 2001). The membrane topology of GLUT2 protein was predicted with the TMHMM program, server 2.0 (http://www.cbs.dtu.dk/services/TMHMM-2.0/).

2.4

2.4 Analysis of nsSNPs by SIFT

Sorting Intolerant from Tolerant (SIFT) is an algorithm that forecasts whether substitution of an amino acid influences protein function or not. It is based on the principle that essential amino acids in a protein family remain conserved, and any replacement at these positions is deleterious, which influences function/activity of protein. Protein sequence in FASTA format along substitution of amino acids was used as input at (http://www.blocks.fhcrc.org/sift/SIFT.html). It then considered the normalized probability for the provided substitution at the related position in the alignment. Substitutions with the normalized probability i.e. Tolerance Index (TI) less than 0.05 were forecasted to be intolerant or harmful whereas substitutions with TI higher than 0.05 were predicted to be tolerant (Adzhubei et al., 2010).

2.5

2.5 Analysis of nsSNPs by using PolyPhen

PolyPhen-2 is a tool for forecasting of the feasible impact of an amino acid substitution on the protein structure and function (Adzhubei et al., 2010). Automated divinations of this type are vital for interpreting rare genetic variants, which may have potential approach in recent research of human genetics. Its importance in modern research involves identification of rare alleles that generate Mendelian disease (Bamshad et al., 2011), scanning for medically important alleles in an individual’s genome (Ashley et al., 2010), and profiling the spectrum of rare variation uncovered by deep sequencing of large populations (Tennessen et al., 2012).

PolyPhen (http://genetics.bwh.harvard.edu/pph2) utilizes UniProtKB database which is used as source of reference. Protein sequence of GLUT2 in FASTA format and position of protein sequence was entered. AA1 wild type (query sequence) as well as substitution reside AA2 were selected. Two pair’s datasets were used. First pair of HumDiv and the second pair; HumVar were compiled in UniProt database.

2.6

2.6 Analysis of nsSNPs by using PROVEAN

PROVEAN is not only effective to predict single amino acid change but it can also perform task for other changes in the protein sequence including indels (deletion and insertion) (Choi et al., 2012). The PROVEAN web server (http://provean.jcvi.org) gives online approach for the functioning of distribution for the software package of stand-alone. Its major role is to give divination from any of organism’s protein sequence. It takes the sequence of protein and variation of amino acid as input. BLAST search was done to recognize the homologous sequence and produce the PROVEAN result. Generally the BLAST search took 10–20 min to produce the divination for a provided protein query. Sequence identifiers list for supporting sequences and clustering data was stored in database. Focused on sequence of query protein consecutive prediction data for supporting sequences were indexed.

2.7

2.7 Analysis of nsSNPs by using SNPeffect

SNPeffect (De Baets et al., 2012) was used to predict the molecular phenotypic influence of nsSNPs lying in coding region of GLUT2 protein. It works beyond the scores got on conservational basis and mainly emphasizes to map the effect of SNPs on the capability of cells to uphold suitable concentration of the properly folded proteins in appropriate cellular region i.e. protein homeostasis landscape (Powers et al., 2009). For this assessment, wild type protein sequence in FASTA format along with each of its variants was given to the SNPeffect server (http://snpeffect.switchlab.org) for analysis. Homology threshold was fixed to 90%. It uses TANGO (Fernandez-Escamilla et al., 2004) which forecasts the regions in given protein sequence that are prone to aggregation and calculated TANGO score with wild and variant amino acid. On the basis of TANGO score difference (dTANGO), the server assesses effect of these variants on protein aggregation. Aggregate morphology is more distinctively evaluated by WALTZ server (Maurer-Stroh et al., 2010) that forecasts amyloid-forming regions in given protein sequence with accuracy and specificity on basis of dWALTZ score. Chaperone binding propensity is forecasted by LIMBO (Van Durme et al., 2009) for the Hsp70 chaperones and effect of variant is determined by dLIMBO score. SNPeffect also uses high resolution crystal structure of proteins from Protein Data Bank (PDB) (Deshpande et al., 2005) and models the variants using the empirical force field FoldX (version 2.5) (Schymkowitz et al., 2005) to determine possible effects on stability and binding properties of given protein.

3

3 Results

3.1

3.1 Phylogenetic analysis

Evolutionary relationship of GLUT2 protein among 10 different species of primates was carried out using human GLUT2 protein as a reference sequence (Fig. 2). The phylogenetic tree generated from Clustal Omega helps to understand the evolutionary relationship of GLUT2 among different species. Evolutionary tree demonstrates that GLUT2 of human and Pongo abelli lie close to each other whereas that of Bos taurusis most distant from human.

Phylogenetic analysis of human GLUT2 protein. A phylogenetic tree of the amino acid sequences of GLUT2 protein was constructed using the Clustal Omega.
Fig. 2
Phylogenetic analysis of human GLUT2 protein. A phylogenetic tree of the amino acid sequences of GLUT2 protein was constructed using the Clustal Omega.

3.2

3.2 Membrane topology

A significant server TMHMM was used to predict the significant features of helices in transmembrane protein and GLUT2 was found to comprise of 12 predicted transmembrane helices with intracellular amino (N-terminal) and carboxyl (C-termini) in cytosol. It also contains extracellular and intracellular loops which are located between the segments of 1st and 2nd transmem brane domains and between 6th and 7th transmembrane segments (Fig. 3). While, the remaining transmembrane segments from seven to twelve have ability to perform transportation of fructose and glucose to the membrane.

Toplogy prediction of human GLUT2 protein. The human GLUT2 protein comprises of 12 predicted transmembrane helices with intracellular amino (N-terminal) and carboxyl (C-termini) in cytosol. It also contains extracellular and intracellular loops which are located between the segments of 1st and 2nd transmembrane domains and between 6th and 7th transmembrane segments.
Fig. 3
Toplogy prediction of human GLUT2 protein. The human GLUT2 protein comprises of 12 predicted transmembrane helices with intracellular amino (N-terminal) and carboxyl (C-termini) in cytosol. It also contains extracellular and intracellular loops which are located between the segments of 1st and 2nd transmembrane domains and between 6th and 7th transmembrane segments.

3.3

3.3 Distribution of SNPs in GLUT2 protein

In the human SLC2A2 gene the non coding region of gene contains 6,628 SNPs in which 83 SNPs were near 3′gene, 340 in 3′UTR, 427 SNPs in 5′ near gene, 62 in 5′UTR and in the intron 5716 SNPs were found (Fig. 4). While the coding region contained 484 SNPs in which 137 SNPs were synonymous, 293 were nsSNPs, 21 were frameshifts; (rs766082034), (rs1447936042), (rs769888108), (rs1255595607), (rs776307487), (rs1162215911), (rs771361095), (rs1326032349), (rs1350704340), (rs1290975016), (rs765132996), (rs1181030797), (rs771799491), (rs746178753), (rs1316522125), (rs748296868), (rs34066960), (rs1174349159), (rs1384674663),(rs1386374799) and (rs1290412048). 11 were nonsense; (rs774841662), (rs771477447), (rs1475086161), (rs1114167428), (rs753629940), (rs773581866), (rs121909746), (rs121909743), (rs121909742), (rs121909745) and (rs1379944645). Out of 7 SNPs, 4 were inframe deletion; (rs772999215), (rs1169887677), (rs763620441), (rs774721090) and 3 were inframe insertion; (rs1161394690), (rs1463507753) and (rs749789723). 10 (rs1294679246), (rs756163471), (rs371977235), (rs1240053337), (rs756874949), (rs1303795800), (rs1281471314), (rs985090030), (rs757587931), (rs867530965) were donor and 4 (rs754220999), (rs1318756243), (rs776248984), (rs1230247311) were acceptor shown (Fig. 5). (rs749789723) SNPs also contain stop gained. 1 SNPs was stop lost (rs750463981). 10 additional SNPs were detected by dbSNP in which 4 SNPs; (rs766082034), (rs1255595607), (rs1162215911), (rs746178753) were frameshifts and 6; (rs766762468), (rs1800572), (rs777020657), (rs867996396), (rs121909747), (rs1309197020) were nsSNPs (Table 1)

Distribution of SNPs in human GLUT2 Protein.
Fig. 4
Distribution of SNPs in human GLUT2 Protein.
Distribution of nsSNPs in coding region of GLUT2 protein.
Fig. 5
Distribution of nsSNPs in coding region of GLUT2 protein.
Table 1 nsSNPs lying in the coding region of human GLUT2.
dbSNP id Function dbSNPallele Codonpos. mRNApos. Proteinresidue Amino acidpos
rs759495940 nsSNPs G /A 3 312 Met [M]/Ile [I] 1
rs773205789 nsSNPs A /C 1 313 Thr [T]/Pro [P] 2
rs200073044 nsSNPs G /C 1 319 Asp [D]/His [H] 4
rs1372689853 nsSNPs A /G 1 322 Lys [K]/Glu [E] 5
rs767313610 nsSNPs G /A 1 325 Val [V]/Ile [I] 6
rs369700669 nsSNPs C /A 2 329 Thr [T]/Asn [N] 7
rs766082034 frame shift G /- 3 333 Thr [T]/Pro [P] 9
rs766082034 frameshift G/- 3 333 (Gly)G/(Gly)G 9
rs1181030797 frame shift G /- 1 340 Val [V]/Phe [F] 11
rs1481905618 nsSNPs C /A 3 345 Phe [F]/Leu [L] 12
rs1247912820 nsSNPs C /A 2 347 Thr [T]/Asn [N] 13
rs1247912820 nsSNPs C /G 2 347 Thr [T]/Ser [S] 13
rs372441014 nsSNPs G /C 1 349 Val [V]/Leu [L] 14
rs766364438 nsSNPs T /C 2 353 Ile [I]/Thr [T] 15
rs1463507753 INFRAME INSERTION TCA 1 355 Ile[I] /IleIle[II] 15
rs867315854 nsSNPs G /A 1 358 Ala [A]/Thr [T] 17
rs761992056 nsSNPs G /A 2 368 Gly [G]/Asp [D] 20
rs369781481 nsSNPs C /A 3 375 Phe [F]/Leu [L] 22
rs1409436045 nsSNPs T /A 2 380 Phe [F]/Tyr [Y] 24
rs1049223265 nsSNPs T /C 2 392 Ile [I]/Thr [T] 28
rs1437312005 nsSNPs G /A 1 394 Gly [G]/Ser [S] 29
rs1437312005 nsSNPs G /C 1 394 Gly [G]/Arg [R] 29
rs775531825 nsSNPs A /G 2 404 Asn [N]/Ser [S] 32
rs143528640 nsSNPs G /A 1 406 Ala [A]/Thr [T] 33
rs746158263 nsSNPs C /A 1 409 Pro [P]/Thr [T] 34
rs774841662 nonsense C/ T 1 412 Gln [Q]/ 35
rs1158195535 nsSNPs C /A 1 415 Gln [Q]/Lys [K] 36
rs1158195535 nsSNPs C /G 1 415 Gln [Q]/Glu [E] 36
rs1451394300 nsSNPs G /A 1 418 Val [V]/Ile [I] 37
rs1477523180 nsSNPs A /C 1 421 Ile [I]/Leu [L] 38
rs1360464436 nsSNPs T /A 2 422 Ile [I]/Lys [K] 38
rs1176350402 nsSNPs T /C 2 425 Ile [I]/Thr [T] 39
rs772999215 Inframe Deletion II [ATA] > I [] 1 424 IleIle[II] / Ile [I] 39
rs758670698 nsSNPs G /T 2 437 Arg [R]/Ile [I] 43
rs760618624 nsSNPs C /T 1 439 His [H]/Tyr [Y] 44
rs775791143 nsSNPs G /A 1 442 Val [V]/Ile [I] 45
rs149108283 nsSNPs T /A 2 443 Val [V]/Asp [D] 45
rs149108283 nsSNPs T /C 2 443 Val [V]/Ala [A] 45
rs1159338702 nsSNPs G /A 1 448 Gly [G]/Ser [S] 47
rs561765982 nsSNPs G /A 1 451 Val [V]/Ile [I] 48
rs983907950 nsSNPs C /T 1 454 Pro [P]/Ser [S] 49
rs1211075508 nsSNPs T /C 2 458 Leu [L]/Pro [P] 50
rs1311902495 nsSNPs G /A 1 463 Asp [D]/Asn [N] 52
rs1311902495 nsSNPs G /T 1 463 Asp [D]/Tyr [Y] 52
rs771477447 nonsense C /T 1 466 Arg [R]/ 53
rs771477447 nsSNPs C /G 1 466 Arg [R]/Gly [G] 53
rs145210664 nsSNPs G /A 2 467 Arg [R]/Gln [Q] 53
rs546539032 nsSNPs A /C 3 471 Lys [K]/Asn [N] 54
rs747555903 nsSNPs G /A 1 487 Val [V]/Ile [I] 60
rs1447936042 frame shift - /(26 bp) 1 490 Ile [I]/Thr [T] 61
rs977284195 nsSNPs T /C 2 491 Ile [I]/Thr [T] 61
rs780903829 nsSNPs C /G 3 492 Ile [I]/Met [M] 61
rs1373290524 nsSNPs G /C 2 497 Ser [S]/Thr [T] 63
rs1310901426 nsSNPs A /G 1 499 Thr [T]/Ala [A] 64
rs1169887677 Inframe Deletion INS [ATCA] / [ACA] 2 491 INS (IleAsnSer) / () 61
rs1354126805 nsSNPs C /G 2 500 Thr [T]/Arg [R] 64
rs754585542 nsSNPs G /A 1 502 Asp [D]/Asn [N] 65
rs1217666649 nsSNPs T /A 3 504 Asp [D]/Glu [E] 65
rs1391257598 nsSNPs C /A 1 511 Pro [P]/Thr [T] 68
rs7637863 nsSNPs C /T 2 512 Pro [P]/Leu [L] 68
rs779977931 nsSNPs C /A 2 515 Thr [T]/Lys [K] 69
rs1182852354 nsSNPs A /G 1 517 Ile [I]/Val [V] 70
rs750405382 nsSNPs A /G 1 529 Met [M]/Val [V] 74
rs1207297111 nsSNPs A /G 1 532 Asn [N]/Asp [D] 75
rs1342979475 nsSNPs A /C 2 533 Asn [N]/Thr [T] 75
rs1274084408 nsSNPs C /G 1 535 Pro [P]/Ala [A] 76
rs778655073 nsSNPs C /T 2 542 Pro [P]/Leu [L] 78
rs769888108 frame shift C /- 2 548 Pro [P]/Leu [L] 80
rs549263048 nsSNPs T /C 1 550 Trp [W]/Arg [R] 81
rs531049536 nsSNPs G /T 3 552 Trp [W]/Cys [C] 81
rs150851401 nsSNPs G /A 1 556 Glu [E]/Lys [K] 83
rs766762468 nsSNPs C /G 2 566 Thr [T]/Ser [S] 86
rs766762468 nsSNPs C/T 2 566 T (Thr) > I (Ile) 86
rs763255363 nsSNPs G /T 1 571 Ala [A]/Ser [S] 88
rs144715667 nsSNPs A /G 1 586 Ile [I]/Val [V] 93
rs1415169647 nsSNPs T /G 2 593 Met [M]/Arg [R] 95
rs1407375423 nsSNPs G /T 3 600 Trp [W]/Cys [C] 97
rs1800572 nsSNPs G /A 1 610 Val [V]/Ile [I] 101
rs1800572 nsSNPs G/C 1 610 Val [V] / Leu [L] 101
rs770135219 nsSNPs T /C 2 611 Val [V]/Ala [A] 101
rs1399091893 nsSNPs C /T 2 623 Ala [A]/Val [V] 105
rs1332764085 nsSNPs G /A 1 625 Val [V]/Ile [I] 106
rs5400 nsSNPs C /T 2 638 Thr [T]/Ile [I] 110
rs377238940 nsSNPs G /C 1 640 Ala [A]/Pro [P] 111
rs1475086161 nonsense C /G 2 644 Ser [S]/ 112
rs1255595607 frame shift C /- 3 648 Phe [F]/Leu [L] 114
rs1255595607 frame shift C /- 3 648 Phe [F]/ Phe [F] 114
rs768407637 nsSNPs G /T 2 656 Gly [G]/Val [V] 116
rs753980727 nsSNPs G /T 3 660 Trp [W]/Cys [C] 117
rs746632604 nsSNPs G /C 2 665 Gly [G]/Ala [A] 119
rs772002572 nsSNPs C /T 2 671 Thr [T]/Ile [I] 121
rs1476520648 nsSNPs T /A 2 683 Ile [I]/Asn [N] 125
rs760201098 nsSNPs C /A 2 689 Ala [A]/Asp [D] 127
rs1267904495 nsSNPs T /C 2 692 Met [M]/Thr [T] 128
rs1212980167 nsSNPs G /C 3 693 Met [M]/Ile [I] 128
rs367856967 nsSNPs T /C 2 698 Val [V]/Ala [A] 130
rs970550665 nsSNPs C /G 2 701 Ala [A]/Gly [G] 131
rs775283150 nsSNPs A /T 1 706 Ile [I]/Phe [F] 133
rs913419413 nsSNPs T /G 2 710 Leu [L]/Arg [R] 134
rs771843187 nsSNPs T /C 1 712 Ser [S]/Pro [P] 135
rs144125084 nsSNPs G /C 1 718 Val [V]/Leu [L] 137
rs993833041 nsSNPs T /C 2 719 Val [V]/Ala [A] 137
rs1300072764 nsSNPs G /A 2 722 Gly [G]/Glu [E] 138
rs778548964 nsSNPs C /T 1 727 Leu [L]/Phe [F] 140
rs776307487 frame shift T /- 2 728 Leu [L]/Pro [P] 140
rs1016384738 nsSNPs T /A 2 734 Met [M]/Lys [K] 142
rs770941010 nsSNPs G /C 1 736 Gly [G]/Arg [R] 143
rs777718289 nsSNPs G /A 2 752 Gly [G]/Glu [E] 148
rs777718289 nsSNPs G /T 2 752 Gly [G]/Val [V] 148
rs372621339 nsSNPs C /G 2 755 Pro [P]/Arg [R] 149
rs747025551 nsSNPs T /C 2 764 Ile [I]/Thr [T] 152
rs376064965 nsSNPs C /T 1 766 Leu [L]/Phe [F] 153
rs1188886679 nsSNPs A /C 1 769 Ile [I]/Leu [L] 154
rs1188886679 nsSNPs A /G 1 769 Ile [I]/Val [V] 154
rs192720796 nsSNPs T /A 2 770 Ile [I]/Lys [K] 154
rs763620441 INFRAME DELETION ILI [CTTATA] / I [] 1 766 IleLeuIle [ILI] / Ile [I] 153
rs910976682 nsSNPs C /T 2 776 Ala [A]/Val [V] 156
rs750836049 nsSNPs G /C 1 778 Gly [G]/Arg [R] 157
rs1278964539 nsSNPs G /A 2 782 Arg [R]/Lys [K] 158
rs1231468128 nsSNPs T /A 2 797 Leu [L]/Gln [Q] 163
rs1445887606 nsSNPs T /C 1 799 Tyr [Y]/His [H] 164
rs1271546287 nsSNPs T /C 2 812 Ile [I]/Thr [T] 168
rs760095835 nsSNPs G /A 2 818 Gly [G]/Asp [D] 170
rs1335888503 nsSNPs G /C 1 823 Val [V]/Leu [L] 172
rs1293130515 nsSNPs T /C 2 830 Met [M]/Thr [T] 174
rs1019696977 nsSNPs A /G 1 835 Ile [I]/Val [V] 176
rs144822218 nsSNPs G /A 1 838 Gly [G]/Ser [S] 177
rs759047405 nsSNPs G /A 2 839 Gly [G]/Asp [D] 177
rs1441606652 nsSNPs C /T 2 848 Ala [A]/Val [V] 180
rs368626129 nsSNPs G /A 1 856 Ala [A]/Thr [T] 183
rs368626129 nsSNPs G /T 1 856 Ala [A]/Ser [S] 183
rs771799491 frame shift G /- 2 866 Gly [G]/Glu [E] 186
rs200213178 nsSNPs G /A 1 868 Ala [A]/Thr [T] 187
rs200213178 nsSNPs G /C 1 868 Ala [A]/Pro [P] 187
rs748052042 nsSNPs C /T 1 871 Leu [L]/Phe [F] 188
rs1412289847 nsSNPs G /A 1 874 Gly [G]/Ser [S] 189
rs776498787 nsSNPs G /A 2 875 Gly [G]/Asp [D] 189
rs779065938 nsSNPs C /G 1 889 Leu [L]/Val [V] 194
rs1469335096 nsSNPs G /A 1 892 Ala [A]/Thr [T] 195
rs771182536 nsSNPs T /A 2 896 Ile [I]/Asn [N] 196
rs771182536 nsSNPs T /C 2 896 Ile [I]/Thr [T] 196
rs121909741 nsSNPs G /A 1 898 Val [V]/Ile [I] 197
rs149460434 nsSNPs C /A 2 902 Thr [T]/Lys [K] 198
rs149460434 nsSNPs C /T 2 902 Thr [T]/Met [M] 198
rs1276756236 nsSNPs C /A 1 910 Leu [L]/Ile [I] 201
rs779591826 nsSNPs T /G 3 924 Ile [I]/Met [M] 205
rs1262860274 nsSNPs T /C 2 926 Ile [I]/Thr [T] 206
rs1186359171 nsSNPs G /A 1 928 Gly [G]/Ser [S] 207
rs1114167428 nonsense G /T 1 934 Glu [E]/ 209
rs1215469128 nsSNPs T /C 2 944 Leu [L]/Ser [S] 212
rs1347267249 nsSNPs A /C 1 949 Asn [N]/His [H] 214
rs573292685 nsSNPs A /G 2 950 Asn [N]/Ser [S] 214
rs764799427 nsSNPs A /T 2 956 Asp [D]/Val [V] 216
rs753629940 nonsense G /A 3 963 Trp [W]/ 218
rs1380319602 nsSNPs T /A 2 968 Ile [I]/Asn [N] 220
rs760641937 nsSNPs G /C 2 977 Gly [G]/Ala [A] 223
rs1413841367 nsSNPs T /C 2 980 Leu [L]/Pro [P] 224
rs771075989 nsSNPs G /A 1 988 Val [V]/Met [M] 227
rs773581866 nonsense C /T 1 991 Arg [R]/ 228
rs773581866 nsSNPs C /G 1 991 Arg [R]/Gly [G] 228
rs770126214 nsSNPs C /A 1 1000 Leu [L]/Ile [I] 231
rs1374154306 nsSNPs T /A 2 1013 Leu [L]/Gln [Q] 235
rs748588515 nsSNPs C /T 1 1015 Leu [L]/Phe [F] 236
rs1162215911 frame shift CT /- 3 1017 Phe [F]/Leu [L] 238
rs1162215911 frame shift CT /- 3 1017 Leu [L] /Leu[L] 238
rs757087261 nsSNPs T /A 1 1021 Phe [F]/Ile [I] 238
rs777020657 nsSNPs T /G 2 1022 Phe [F]/Cys [C] 238
rs777020657 nsSNPs T/C 2 1022 Phe [F] /Ser[S] 238
rs769089021 nsSNPs G /A 2 1034 Ser [S]/Asn [N] 242
rs780381836 nsSNPs A /G 1 1039 Arg [R]/Gly [G] 244
rs1480881050 nsSNPs T /C 1 1042 Tyr [Y]/His [H] 245
rs1250722271 nsSNPs T /C 1 1048 Tyr [Y]/His [H] 247
rs1158317020 nsSNPs A /T 2 1049 Tyr [Y]/Phe [F] 247
rs867996396 nsSNPs T /A 2 1052 Ile [I]/Asn [N] 248
rs867996396 nsSNPs T/C 2 1052 Ile [I] / Thr [T] 248
rs536261161 nsSNPs G /C 3 1056 Lys [K]/Asn [N] 249
rs745373269 nsSNPs G /A 1 1060 Asp [D]/Asn [N] 251
rs745373269 nsSNPs G /C 1 1060 Asp [D]/His [H] 251
rs1367431424 nsSNPs A /C 2 1064 Glu [E]/Ala [A] 252
rs865881030 nsSNPs G /A 1 1066 Glu [E]/Lys [K] 253
rs778607566 nsSNPs A /G 2 1067 Glu [E]/Gly [G] 253
rs1309254226 nsSNPs A /C 3 1068 Glu [E]/Asp [D] 253
rs777225980 nsSNPs C /A 3 1086 Ser [S]/Arg [R] 259
rs76026576 nsSNPs G /T 3 1089 Leu [L]/Phe [F] 260
rs746178753 frame shift AG /- 3 1101 Gly [G]/Ile [I] 265
rs746178753 frame shift AG /- 3 1101 Arg [R]/ Arg[R] 265
rs1490504926 nsSNPs G /A 1 1108 Asp [D]/Asn [N] 267
rs935009475 nsSNPs T /A 3 1113 Asp [D]/Glu [E] 268
rs774721090 Inframe Deletion DD [GATG] / D [GTC] 2 1112 AspAsp[DD]/ Asp [D] 268
rs140285191 nsSNPs G /A 1 1123 Asp [D]/Asn [N] 272
rs140285191 nsSNPs G /T 1 1123 Asp [D]/Tyr [Y] 272
rs754932741 nsSNPs G /A 3 1137 Met [M]/Ile [I] 276
rs750579210 nsSNPs A /G 1 1138 Arg [R]/Gly [G] 277
rs1304842107 nsSNPs A /C 1 1141 Lys [K]/Gln [Q] 278
rs765426962 nsSNPs A /C 2 1142 Lys [K]/Thr [T] 278
rs761756532 nsSNPs A /C 3 1143 Lys [K]/Asn [N] 278
rs771361095 frame shift -/A 1 1147 Arg [R]/Lys [K] 280
rs1329237779 nsSNPs G /A 1 1153 Glu [E]/Lys [K] 282
rs1384542256 nsSNPs A /C 2 1154 Glu [E]/Ala [A] 282
rs776912318 nsSNPs A /C 1 1162 Ser [S]/Arg [R] 285
rs776912318 nsSNPs A /T 1 1162 Ser [S]/Cys [C] 285
rs121909746 nonsense C /T 1 1168 Gln [Q]/ 287
rs764161243 nsSNPs A /C 2 1172 Lys [K]/Thr [T] 288
rs780873643 nsSNPs T /G 2 1175 Val [V]/Gly [G] 289
rs775691314 nsSNPs C /G 2 1178 Ser [S]/Cys [C] 290
rs772619265 nsSNPs A /G 1 1180 Ile [I]/Val [V] 291
rs760061096 nsSNPs T /A 2 1181 Ile [I]/Lys [K] 291
rs749789723 inframe insertion/stop gained TTT 2 1181 Leu [L] 291
rs1205719797 nsSNPs T /A 2 1190 Leu [L]/His [H] 294
rs1364855365 nsSNPs C /G 2 1196 Thr [T]/Ser [S] 296
rs368432491 nsSNPs A /G 2 1199 Asn [N]/Ser [S] 297
rs182778895 nsSNPs T /C 1 1201 Ser [S]/Pro [P] 298
rs777540740 nsSNPs A /T 1 1204 Ser [S]/Cys [C] 299
rs769325995 nsSNPs T /C 1 1207 Tyr [Y]/His [H] 300
rs121909743 nonsense C /T 1 1210 Arg [R]/ 301
rs374492763 nsSNPs G /A 2 1211 Arg [R]/Gln [Q] 301
rs374492763 nsSNPs G /T 2 1211 Arg [R]/Leu [L] 301
rs1326032349 frame shift -/TTGG 3 1212 Gln [Q]/Leu [L] 302
rs1316522125 frame shift C /- 2 1217 Pro [P]/Leu [L] 303
rs938526894 nsSNPs T /C 2 1223 Leu [L]/Pro [P] 305
rs1312418962 nsSNPs T /C 2 1235 Met [M]/Thr [T] 309
rs1421580115 nsSNPs G /A 1 1243 Val [V]/Met [M] 312
rs1324205444 nsSNPs G /A 1 1246 Ala [A]/Thr [T] 313
rs1324205444 nsSNPs G /T 1 1246 Ala [A]/Ser [S] 313
rs780067980 nsSNPs G /A 1 1261 Gly [G]/Arg [R] 318
rs369101584 nsSNPs A /G 2 1268 Asn [N]/Ser [S] 320
rs757366672 nsSNPs G /T 1 1270 Gly [G]/Cys [C] 321
rs767670296 nsSNPs T /A 2 1274 Ile [I]/Asn [N] 322
rs1272816101 nsSNPs T /G 3 1275 Ile [I]/Met [M] 322
rs759952425 nsSNPs T /C 1 1282 Tyr [Y]/His [H] 325
rs751917665 nsSNPs C /T 2 1304 Thr [T]/Met [M] 332
rs1441375275 nsSNPs G /A 1 1306 Ala [A]/Thr [T] 333
rs763345848 nsSNPs G /A 2 1310 Gly [G]/Asp [D] 334
rs748296868 frame shift G /- 2 1310 Gly [G]/Val [V] 334
rs1461795294 nsSNPs A /G 1 1315 Ser [S]/Gly [G] 336
rs773717998 nsSNPs C /A 2 1334 Thr [T]/Asn [N] 342
rs1162318193 nsSNPs T /C 2 1337 Ile [I]/Thr [T] 343
rs1050103029 nsSNPs T /C 2 1343 Val [V]/Ala [A] 345
rs764683908 nsSNPs G /A 2 1346 Gly [G]/Asp [D] 346
rs776435170 nsSNPs G /A 1 1348 Ala [A]/Thr [T] 347
rs1236921754 nsSNPs C /T 2 1349 Ala [A]/Val [V] 347
rs746863503 nsSNPs T /G 2 1358 Met [M]/Arg [R] 350
rs775407568 nsSNPs G /C 3 1359 Met [M]/Ile [I] 350
rs771855037 nsSNPs G /A 1 1369 Ala [A]/Thr [T] 354
rs140815551 nsSNPs G /A 1 1372 Val [V]/Ile [I] 355
rs1348497054 nsSNPs C /G 2 1376 Ser [S]/Cys [C] 356
rs1469035471 nsSNPs G /C 1 1378 Val [V]/Leu [L] 357
rs372845210 nsSNPs C /A 1 1384 Leu [L]/Ile [I] 359
rs372845210 nsSNPs C /T 1 1384 Leu [L]/Phe [F] 359
rs1380054283 nsSNPs G /C 1 1390 Glu [E]/Gln [Q] 361
rs999185720 nsSNPs G /T 3 1392 Glu [E]/Asp [D] 361
rs745619267 nsSNPs G /C 3 1395 Lys [K]/Asn [N] 362
rs76362149 nsSNPs G /T 1 1396 Ala [A]/Ser [S] 363
rs121909742 nonsense C /T 1 1402 Arg [R]/ 365
rs34066960 frame shift -/C 3 1401 Arg [R]/Pro [P] 365
rs781225543 nsSNPs G /A 2 1403 Arg [R]/Gln [Q] 365
rs1321655963 nsSNPs C /T 1 1405 Arg [R]/Cys [C] 366
rs755000812 nsSNPs G /A 2 1406 Arg [R]/His [H] 366
rs1174349159 frame shift CT /- 3 1413 Phe [F]/Ser [S] 369
rs1223071449 nsSNPs T /A 3 1416 Phe [F]/Leu [L] 369
rs1430684701 nsSNPs T /C 2 1418 Leu [L]/Pro [P] 370
rs747262541 nsSNPs G /A 2 1430 Ser [S]/Asn [N] 374
rs868182136 nsSNPs G /A 2 1433 Gly [G]/Glu [E] 375
rs780255530 nsSNPs A /G 1 1435 Met [M]/Val [V] 376
rs758699271 nsSNPs G /A 3 1437 Met [M]/Ile [I] 376
rs946622803 nsSNPs T /C 1 1438 Phe [F]/Leu [L] 377
rs1381085405 nsSNPs T /A 2 1439 Phe [F]/Tyr [Y] 377
rs1381085405 nsSNPs T /C 2 1439 Phe [F]/Ser [S] 377
rs1384674663 frame shift TTGT /- 3 1443 Cys [C]/Pro [P] 379
rs750782646 nsSNPs T /A 2 1451 Ile [I]/Asn [N] 381
rs765728439 nsSNPs T /C 2 1457 Met [M]/Thr [T] 383
rs757805176 nsSNPs G /A 1 1465 Gly [G]/Arg [R] 386
rs757805176 nsSNPs G /C 1 1465 Gly [G]/Arg [R] 386
rs1199637811 nsSNPs T /G 2 1472 Val [V]/Gly [G] 388
rs121909747 nsSNPs T /G 2 1475 Leu [L]/Arg [R] 389
rs 121,909,747 nsSNPs T/C 2 1475 L (Leu) > P (Pro) 389
rs760200790 nsSNPs T /G 2 1478 Leu [L]/Arg [R] 390
rs766191732 nsSNPs C /A 3 1488 Phe [F]/Leu [L] 393
rs1464417991 nsSNPs T /C 1 1489 Ser [S]/Pro [P] 394
rs762668792 nsSNPs T /A 2 1505 Val [V]/Glu [E] 399
rs1457657980 nsSNPs A /G 1 1510 Met [M]/Val [V] 401
rs374702599 nsSNPs T /C 2 1514 Ile [I]/Thr [T] 402
rs1161394690 inframe insertion GAT 2 1514 Met [M]/ MetMet [MM] 401
rs1419532672 nsSNPs A /G 1 1519 Ile [I]/Val [V] 404
rs2229608 nsSNPs T /C 2 1520 Ile [I]/Thr [T] 404
rs760729620 nsSNPs T /C 2 1529 Phe [F]/Ser [S] 407
rs140791627 nsSNPs A /T 1 1534 Ser [S]/Cys [C] 409
rs746136121 nsSNPs T /C 1 1537 Phe [F]/Leu [L] 410
rs1353890919 nsSNPs T /G 2 1541 Phe [F]/Cys [C] 411
rs966424064 nsSNPs T/ C 2 1547 Ile [I]/Thr [T] 413
rs779212294 nsSNPs T /G 3 1548 Ile [I]/Met [M] 413
rs121909744 nsSNPs C /G 2 1559 Pro [P]/Arg [R] 417
rs121909744 nsSNPs C /T 2 1559 Pro [P]/Leu [L] 417
rs1309197020 nsSNPs C /G 3 1563 Ile [I]/Met [M] 418
rs1309197020 nsSNPs C/A 3 1563 Ile [I] / Ile [I] 418
rs121909745 nonsense G /A 2 1568 Trp [W]/ 420
rs749661374 nsSNPs A /G 1 1573 Met [M]/Val [V] 422
rs778490867 nsSNPs T /C 2 1574 Met [M]/Thr [T] 422
rs28928874 nsSNPs T /A 2 1577 Val [V]/Glu [E] 423
rs1386374799 frame shift T /- 2 1589 Phe [F]/Ser [S] 427
rs367980651 nsSNPs C /T 1 1603 Arg [R]/Cys [C] 432
rs75144723 nsSNPs G /A 2 1604 Arg [R]/His [H] 432
rs754405476 nsSNPs G /A 1 1612 Ala [A]/Thr [T] 435
rs1379813904 nsSNPs C /A 2 1619 Ala [A]/Glu [E] 437
rs751226875 nsSNPs T /C 2 1622 Ile [I]/Thr [T] 438
rs762675284 nsSNPs G /T 1 1624 Ala [A]/Ser [S] 439
rs1262058831 nsSNPs C /T 2 1625 Ala [A]/Val [V] 439
rs758246412 nsSNPs C /A 2 1628 Ala [A]/Glu [E] 440
rs1203908311 nsSNPs A /G 2 1637 Asn [N]/Ser [S] 443
rs765196886 nsSNPs A /C 1 1654 Ile [I]/Leu [L] 449
rs761784655 nsSNPs T /C 2 1655 Ile [I]/Thr [T] 449
rs776395971 nsSNPs T /C 2 1658 Val [V]/Ala [A] 450
rs1238600269 nsSNPs G /A 1 1660 Ala [A]/Thr [T] 451
rs1418589512 nsSNPs T /C 1 1666 Cys [C]/Arg [R] 453
rs1350704340 frame shift -/G 3 1665 Cys [C]/Val [V] 453
rs759480075 nsSNPs T /C 1 1675 Tyr [Y]/His [H] 456
rs771274850 nsSNPs T /C 2 1679 Ile [I]/Thr [T] 457
rs749710583 nsSNPs C /A 2 1682 Ala [A]/Glu [E] 458
rs749710583 nsSNPs C /T 2 1682 Ala [A]/Val [V] 458
rs1290975016 frame shift -/T 2 1688 Cys [C]/Leu [L] 461
rs774542648 nsSNPs G /A 1 1693 Gly [G]/Arg [R] 462
rs765132996 frame shift G /- 2 1694 Gly [G]/Asp [D] 462
rs1272353608 nsSNPs C /A 2 1697 Pro [P]/His [H] 463
rs1381049817 nsSNPs A /G 2 1700 Tyr [Y]/Cys [C] 464
rs1336322605 nsSNPs T /C 1 1708 Phe [F]/Leu [L] 467
rs140138702 nsSNPs C /G 1 1711 Leu [L]/Val [V] 468
rs770197371 nsSNPs T /G 2 1712 Leu [L]/Arg [R] 468
rs748401954 nsSNPs T /C 2 1715 Phe [F]/Ser [S] 469
rs1290412048 frame shift TT /- 2 1715 Phe [F]/Cys [C] 469
rs374342938 nsSNPs G /C 2 1721 Gly [G]/Ala [A] 471
rs769037887 nsSNPs G /A 1 1723 Val [V]/Met [M] 472
rs556023421 nsSNPs T /C 1 1735 Phe [F]/Leu [L] 476
rs5397 nsSNPs C /G 1 1741 Leu [L]/Val [V] 478
rs5398 nsSNPs C /A 3 1746 Phe [F]/Leu [L] 479
rs757137603 nsSNPs C /T 2 1748 Thr [T]/Ile [I] 480
rs1441249949 nsSNPs T /A 1 1750 Phe [F]/ Ile [I] 481
rs1195253424 nsSNPs G /A 1 1759 Val [V]/Ile [I] 484
rs753575081 nsSNPs C /A 1 1762 Pro [P]/Thr [T] 485
rs777806589 nsSNPs A /G 2 1772 Lys [K]/Arg [R] 488
rs766600474 nsSNPs T /A 1 1780 Ser [S]/Thr [T] 491
rs766600474 nsSNPs T /G 1 1780 Ser [S]/Ala [A] 491
rs1379944645 nonsense G /T 1 1786 Glu [E]/ 493
rs1379944645 nsSNPs G /A 1 1786 Glu [E]/Lys [K] 493
rs1353603250 nsSNPs G /C 1 1789 Glu [E]/Gln [Q] 494
rs1446857276 nsSNPs A /T 3 1791 Glu [E]/Asp [D] 494
rs1283734332 nsSNPs T /C 2 1793 Ile [I]/Thr [T] 495
rs1445660295 nsSNPs C /T 2 1796 Ala [A]/Val [V] 496
rs201797691 nsSNPs G /A 1 1798 Ala [A]/Thr [T] 497
rs201797691 nsSNPs G /C 1 1798 Ala [A]/Pro [P] 497
rs200160167 nsSNPs C /A 2 1799 Ala [A]/Glu [E] 497
rs200160167 nsSNPs C /T 2 1799 Ala [A]/Val [V] 497
rs762305192 nsSNPs T /C 1 1804 Phe [F]/Leu [L] 499
rs776826621 nsSNPs G /C 3 1812 Lys [K]/Asn [N] 501
rs5399 nsSNPs G /C 3 1815 Lys [K]/Asn [N] 502
rs1412427073 nsSNPs G /A 1 1819 Gly [G]/Ser [S] 504
rs966895511 nsSNPs G /T 1 1825 Ala [A]/Ser [S] 506
rs1199349184 nsSNPs C /T 2 1826 Ala [A]/Val [V] 506
rs374630641 nsSNPs G /C 3 1833 Arg [R]/Ser [S] 508
rs771586150 nsSNPs C /A 2 1835 Pro [P]/Gln [Q] 509
rs776597156 nsSNPs A /C 3 1839 Lys [K]/Asn[N] 510
rs770462591 nsSNPs C /A 2 1841 Ala [A]/Asp [D] 511
rs770462591 nsSNPs C /T 2 1841 Ala [A]/Val [V] 511
rs141574520 nsSNPs T /A 2 1859 Phe [F]/Tyr [Y] 517
rs147959014 nsSNPs G /A 2 1865 Gly [G]/Glu [E] 519
rs752687355 nsSNPs A /G 2 1874 Glu [E]/Gly[G] 522
rs781215842 nsSNPs A /T 1 1876 Thr [T]/Ser [S] 523
rs758607933 nsSNPs G/ A 1 1879 Val[V]/Met[M] 524
rs750463981 stop lost T /C 1 1882 (Ter) /Gln[Q] 525

3.4

3.4 Analysis of nsSNPS using SIFT

SIFT forecasts whether amino acid substitution in protein has phenotypic effect or not. Alignment also gave forecasted changes of all amino acid locations. The SIFT intolerance index starting point was 0.05. The color code of non polar, basic, uncharged polar and acidic amino acids were shown by black, red, green and blue color respectively. On the other hand, the amino acid alignment is shown by capital letter while the results of prediction are shown by small letter. 'Seq Rep' was the proportion of sequences that has one of the important amino acids. The position either severely gapped or unalignable was determined by low fraction and it has little information which has poor prediction. Its prediction score ranges from 0 to 1. On phenotypic substitution by aligning orthologous and paralogous protein sequence, this study mainly considers the physical properties of amino acids, effect of natural nsSNPs and alignment of homologous sequences (Noreen et al., 2015a, 2015b). For positions 1–524 of amino acids, the prediction of possible substitutions was made (Figure 6). It was used to predict damaging and tolerated effect of 293 nsSNPs that occurs in coding region of GLUT2 protein. As a consequence, 167 were predicted to be damaging (Table 2).

Table 2 SIFT, PolyPhen and PROVEAN analysis of nsSNPs in coding region of human GLUT2 protein.
dbSNP id Proteinresidue SIFT score SIFTprediction PolyPhenscore PolyPhenprediction PROVEANscore PROVEAN prediction
rs759495940 Met [M]/Ile [I] 0.02 Intolerant 0.016 Benign −1.576 Neutral
rs773205789 Thr [T]/Pro [P] 0.08 Tolerant 0.003 Benign −0.251 Neutral
rs200073044 Asp [D]/His [H] 0.16 Tolerant 0.001 Benign −1.256 Neutral
rs1372689853 Lys [K]/Glu [E] 0.27 Tolerant 0.009 Benign −1.503 Neutral
rs767313610 Val [V]/Ile [I] 0.24 Tolerant 0.003 Benign 0.189 Neutral
rs369700669 Thr [T]/Asn [N] 0.05 Tolerant 0.505 Possibly damaging −4.345 Deleterious
rs1481905618 Phe [F]/Leu [L] 1 Tolerant 0.002 Benign −1.974 Neutral
rs1247912820 Thr [T]/Asn [N] 0 Intolerant 0.255 Benign −1.769 Neutral
rs1247912820 Thr [T]/Ser [S] 0.37 Tolerant 0.007 Benign 0.439 Neutral
rs372441014 Val [V]/Leu [L] 0.04 Intolerant 0.534 Possibly damaging −2.404 Neutral
rs766364438 Ile [I]/Thr [T] 0.48 Tolerant 0.007 Benign −0.108 Neutral
rs1463507753 I (Ile) > II (IleIle)
rs867315854 Ala [A]/Thr [T] 0 Intolerant 0.951 Probably damaging −3.332 Deleterious
rs761992056 Gly [G]/Asp [D] 0 Intolerant 0.967 Probably damaging −5.211 Deleterious
rs369781481 Phe [F]/Leu [L] 1 Tolerant 0.253 Benign −0.832 Neutral
rs1409436045 Phe [F]/Tyr [Y] 0.08 Tolerant 0.582 Possibly damaging −1.774 Neutral
rs1049223265 Ile [I]/Thr [T] 0.61 Tolerant 0.041 Benign −0.47 Neutral
rs1437312005 Gly [G]/Ser [S] 0 Intolerant 0.996 Probably damaging −5.242 Deleterious
rs1437312005 Gly [G]/Arg [R] 0 Intolerant 1 Probably damaging −6.99 Deleterious
rs775531825 Asn [N]/Ser [S] 0 Intolerant 0.979 Probably damaging −4.384 Deleterious
rs143528640 Ala [A]/Thr [T] 0.05 Tolerant 0.934 Probably damaging −3.505 Deleterious
rs746158263 Pro [P]/Thr [T] 0 Intolerant 0.999 Probably damaging −7.021 Deleterious
rs1158195535 Gln [Q]/Lys [K] 1 Tolerant 0.004 Benign 0.622 Neutral
rs1158195535 Gln [Q]/Glu [E] 0.14 Tolerant 0.002 Benign −0.245 Neutral
rs1451394300 Val [V]/Ile [I] 0.59 Tolerant 0.006 Benign −0.067 Neutral
rs1477523180 Ile [I]/Leu [L] 0.16 Tolerant 0.437 Benign −1.338 Neutral
rs1360464436 Ile [I]/Lys [K] 0 Intolerant 0.977 Probably damaging −4.893 Deleterious
rs1176350402 Ile [I]/Thr [T] 0.02 Intolerant 0.012 Benign 0.3 Neutral
rs772999215 II (IleIle) > I (Ile) −4.083 Deleterious
rs758670698 Arg [R]/Ile [I] 0.14 Tolerant 0.016 Benign −2.042 Neutral
rs760618624 His [H]/Tyr [Y] 0.04 Intolerant 0 Benign −1.705 Neutral
rs775791143 Val [V]/Ile [I] 0.09 Tolerant 0.098 Benign −0.283 Neutral
rs149108283 Val [V]/Asp [D] 0.02 Intolerant 0.689 Possibly damaging −2.294 Neutral
rs149108283 Val [V]/Ala [A] 0.14 Tolerant 0.034 Benign −1.116 Neutral
rs1159338702 Gly [G]/Ser [S] 0.01 Intolerant 0.653 Possibly damaging −1.878 Neutral
rs561765982 Val [V]/Ile [I] 0.11 Tolerant 0.006 Benign −0.204 Neutral
rs983907950 Pro [P]/Ser [S] 0.41 Tolerant 0.004 Benign −1.397 Neutral
rs1211075508 Leu [L]/Pro [P] 0.32 Tolerant 0.01 Benign −1.458 Neutral
rs1311902495 Asp [D]/Asn[N] 0.34 Tolerant 0.493 Possibly damaging −0.762 Neutral
rs1311902495 Asp [D]/Tyr [Y] 0.01 Intolerant 0.873 Possibly damaging −2.194 Neutral
rs771477447 Arg [R]/Gly [G] 0.05 Tolerant 0.013 Benign −1.477 Neutral
rs145210664 Arg [R]/Gln [Q] 0.18 Tolerant 0.039 Benign −0.58 Neutral
rs546539032 Lys [K]/Asn [N] 0.48 Tolerant 0.038 Benign −0.733 Neutral
rs747555903 Val [V]/Ile [I] 0.43 Tolerant 0.006 Benign −0.048 Neutral
rs977284195 Ile [I]/Thr [T] 0.65 Tolerant 0.003 Benign −0.17 Neutral
rs780903829 Ile [I]/Met [M] 0.17 Tolerant 0.006 Benign −0.304 Neutral
rs1169887677 INS (IleAsnSer) > ()
rs1373290524 Ser [S]/Thr [T] 0.61 Tolerant 0.005 Benign −0.656 Neutral
rs1310901426 Thr [T]/Ala [A] 0.78 Tolerant 0.484 Possibly damaging −1.49 Neutral
rs1354126805 Thr [T]/Arg [R] 0.53 Tolerant 0.93 Probably damaging −1.61 Neutral
rs754585542 Asp [D]/Asn[N] 0.6 Tolerant 0.003 Benign −0.514 Neutral
rs1217666649 Asp [D]/Glu [E] 1 Tolerant 0.001 Benign −0.257 Neutral
rs1391257598 Pro [P]/Thr [T] 0.01 Intolerant 0.005 Benign −0.821 Neutral
rs7637863 Pro [P]/Leu [L] 0.05 Intolerant 0.005 Benign −0.881 Neutral
rs779977931 Thr [T]/Lys [K] 0.16 Tolerant 0.037 Benign −0.951 Neutral
rs1182852354 Ile [I]/Val [V] 0.67 Tolerant 0.001 Benign 0.053 Neutral
rs750405382 Met [M]/Val[V] 0.6 Tolerant 0.001 Benign 0.191 Neutral
rs1207297111 Asn [N]/Asp[D] 0.84 Tolerant 0.001 Benign −0.029 Neutral
rs1342979475 Asn [N]/Thr [T] 0.69 Tolerant 0 Benign 0.053 Neutral
rs1274084408 Pro [P]/Ala [A] 0.73 Tolerant 0.01 Benign −0.158 Neutral
rs778655073 Pro [P]/Leu [L] 0.01 Intolerant 0.258 Benign −1.466 Neutral
rs549263048 Trp [W]/Arg [R] 0.07 Tolerant 0 Benign −1.382 Neutral
rs531049536 Trp [W]/Cys [C] 0.03 Intolerant 0.069 Benign −1.624 Neutral
rs150851401 Glu [E]/Lys [K] 0.03 Intolerant 0.004 Benign −0.777 Neutral
rs766762468 Thr [T]/Ser [S] 0.71 Tolerant 0.004 Benign −0.271 Neutral
rs766762468 Thr (T)/ Ile (I) 0.18 Tolerant 0.039 Benign −0.862 Neutral
rs763255363 Ala [A]/Ser [S] 0.74 Tolerant 0.016 Benign 0.281 Neutral
rs144715667 Ile [I]/Val [V] 0.53 Tolerant 0.002 Benign −0.043 Neutral
rs1415169647 Met [M]/Arg[R] 0.07 Tolerant 0.179 Benign −2.363 Neutral
rs1407375423 Trp [W]/Cys [C] 0 Intolerant 0.999 Probably damaging −11.435 Deleterious
rs1800572 Val [V]/Ile [I] 0 Intolerant 0.997 Probably damaging −0.887 Neutral
rs1800572 Val [V] / Leu[L] 0 Intolerant 0.996 Probably damaging −2.66 Deleterious
rs770135219 Val [V]/Ala [A] 0 Intolerant 0.991 Probably damaging −3.541 Deleterious
rs1399091893 Ala [A]/Val [V] 0 Intolerant 0.542 Possibly damaging −2.559 Deleterious
rs1332764085 Val [V]/Ile [I] 0.39 Tolerant 0.026 Benign −0.536 Neutral
rs5400 Thr [T]/Ile [I] 1 Tolerant 0 Benign 3.394 Neutral
rs377238940 Ala [A]/Pro [P] 0.01 Intolerant 0.808 Possibly damaging −2.114 Neutral
rs768407637 Gly [G]/Val [V] 0 Intolerant 0.996 Probably damaging −6.815 Deleterious
rs753980727 Trp [W]/Cys [C] 0.01 Intolerant 0.704 Possibly damaging −2.72 Deleterious
rs746632604 Gly [G]/Ala [A] 1 Tolerant 0.011 Benign −0.025 Neutral
rs772002572 Thr [T]/Ile [I] 0.02 Intolerant 0.003 Benign −1.408 Neutral
rs1476520648 Ile [I]/Asn [N] 0.09 Tolerant 0.18 Benign −0.471 Neutral
rs760201098 Ala [A]/Asp [D] 0.03 Intolerant 0.616 Possibly damaging −2.467 Neutral
rs1267904495 Met [M]/Thr [T] 0 Intolerant 0.799 Possibly damaging −5.134 Deleterious
rs1212980167 Met [M]/Ile [I] 0 Intolerant 0.175 Benign −3.41 Deleterious
rs367856967 Val [V]/Ala [A] 0.27 Tolerant 0.004 Benign −1.196 Neutral
rs970550665 Ala [A]/Gly [G] 0.53 Tolerant 0.526 Possibly damaging −1.704 Neutral
rs775283150 Ile [I]/Phe [F] 0.05 Tolerant 0.082 Benign −2.379 Neutral
rs913419413 Leu [L]/Arg [R] 0 Intolerant 0.954 Probably damaging −4.778 Deleterious
rs771843187 Ser [S]/Pro [P] 0 Intolerant 0.82 Possibly damaging −2.268 Neutral
rs144125084 Val [V]/Leu [L] 0.75 Tolerant 0.006 Benign −0.509 Neutral
rs993833041 Val [V]/Ala [A] 0.6 Tolerant 0.004 Benign −1.391 Neutral
rs1300072764 Gly [G]/Glu [E] 0 Intolerant 0.991 Probably damaging −5.45 Deleterious
rs778548964 Leu [L]/Phe [F] 0.65 Tolerant 0.125 Benign −1.799 Neutral
rs1016384738 Met [M]/Lys[K] 0 Intolerant 0.979 Probably damaging −5.027 Deleterious
rs770941010 Gly [G]/Arg [R] 0 Intolerant 0.89 Possibly damaging −5.634 Deleterious
rs777718289 Gly [G]/Glu [E] 0.02 Intolerant 0.588 Possibly damaging −3.269 Deleterious
rs777718289 Gly [G]/Val [V] 0.04 Intolerant 0.065 Benign −3.177 Deleterious
rs372621339 Pro [P]/Arg [R] 0.54 Tolerant 0.017 Benign −0.696 Neutral
rs747025551 Ile [I]/Thr [T] 0.14 Tolerant 0.158 Benign 0.37 Neutral
rs376064965 Leu [L]/Phe [F] 0 Intolerant 0.114 Benign −2.421 Neutral
rs763620441 ILI (IleLeuIle) /I(Ile)
rs1188886679 Ile [I]/Leu [L] 1 Tolerant 0.006 Benign −0.029 Neutral
rs1188886679 Ile [I]/Val [V] 0.28 Tolerant 0.02 Benign −0.518 Neutral
rs192720796 Ile [I]/Lys [K] 0 Intolerant 0.616 Possibly damaging −4.296 Deleterious
rs910976682 Ala [A]/Val [V] 0.24 Tolerant 0.007 Benign 0.447 Neutral
rs750836049 Gly [G]/Arg [R] 0 Intolerant 0.996 Probably damaging −7.236 Deleterious
rs1278964539 Arg [R]/Lys [K] 0 Intolerant 0.999 Probably damaging −2.714 Deleterious
rs1231468128 Leu [L]/Gln [Q] 0 Intolerant 0.951 Probably damaging −4.187 Deleterious
rs1445887606 Tyr [Y]/His [H] 0.08 Tolerant 0.319 Benign −3.492 Deleterious
rs1271546287 Ile [I]/Thr [T] 1 Tolerant 0.007 Benign 0.249 Neutral
rs760095835 Gly [G]/Asp [D] 0 Intolerant 0.998 Probably damaging −6.71 Deleterious
rs1335888503 Val [V]/Leu [L] 0 Intolerant 0.48 Possibly damaging −2.654 Deleterious
rs1293130515 Met [M]/Thr [T] 0 Intolerant 0.792 Possibly damaging −5.465 Deleterious
rs1019696977 Ile [I]/Val [V] 1 Tolerant 0.014 Benign −0.016 Neutral
rs144822218 Gly [G]/Ser [S] 0.19 Tolerant 0.153 Benign −4.8 Deleterious
rs759047405 Gly [G]/Asp [D] 0 Intolerant 0.275 Benign −6.064 Deleterious
rs1441606652 Ala [A]/Val [V] 0 Intolerant 0.93 Probably damaging −3.261 Deleterious
rs368626129 Ala [A]/Thr [T] 0.8 Tolerant 0.015 Benign −0.903 Neutral
rs368626129 Ala [A]/Ser [S] 0.86 Tolerant 0.012 Benign −0.098 Neutral
rs200213178 Ala [A]/Thr [T] 0 Intolerant 0.838 Possibly damaging −3.928 Deleterious
rs200213178 Ala [A]/Pro [P] 0 Intolerant 0.996 Probably damaging −4.91 Deleterious
rs748052042 Leu [L]/Phe [F] 0.31 Tolerant 0.044 Benign −1.051 Neutral
rs1412289847 Gly [G]/Ser [S] 0 Intolerant 0.994 Probably damaging −5.883 Deleterious
rs776498787 Gly [G]/Asp [D] 0 Intolerant 0.999 Probably damaging −6.867 Deleterious
rs779065938 Leu [L]/Val [V] 0.03 Intolerant 0.951 Probably damaging −2.948 Deleterious
rs1469335096 Ala [A]/Thr [T] 0.01 Intolerant 0.688 Possibly damaging −2.844 Deleterious
rs771182536 Ile [I]/Asn [N] 0 Intolerant 0.961 Probably damaging −6.383 Deleterious
rs771182536 Ile [I]/Thr [T] 0.02 Intolerant 0.517 Possibly damaging −4.26 Deleterious
rs121909741 Val [V]/Ile [I] 0.01 Intolerant 0.846 Possibly damaging −0.978 Neutral
rs149460434 Thr [T]/Lys [K] 0 Intolerant 0.665 Possibly damaging −3.176 Deleterious
rs149460434 Thr [T]/Met[M] 0.01 Intolerant 0.166 Benign −0.836 Neutral
rs1276756236 Leu [L]/Ile [I] 0 Intolerant 0.967 Probably damaging −1.897 Neutral
rs779591826 Ile [I]/Met [M] 0 Intolerant 0.973 Probably damaging −2.473 Neutral
rs1262860274 Ile [I]/Thr [T] 0.01 Intolerant 0.102 Benign −2.589 Deleterious
rs1186359171 Gly [G]/Ser [S] 0 Intolerant 0.982 Probably damaging −5.869 Deleterious
rs1215469128 Leu [L]/Ser [S] 0 Intolerant 0.993 Probably damaging −4.95 Deleterious
rs1347267249 Asn [N]/His [H] 0.01 Intolerant 0.413 Benign −3.346 Deleterious
rs573292685 Asn [N]/Ser [S] 0.88 Tolerant 0.048 Benign −1.171 Neutral
rs764799427 Asp [D]/Val [V] 0.08 Tolerant 0.027 Benign −3.592 Deleterious
rs1380319602 Ile [I]/Asn [N] 0 Intolerant 0.863 Possibly damaging −5.167 Deleterious
rs760641937 Gly [G]/Ala [A] 0.26 Tolerant 0.401 Benign −3.395 Deleterious
rs1413841367 Leu [L]/Pro [P] 0 Intolerant 0.996 Probably damaging −5.774 Deleterious
rs771075989 Val [V]/Met [M] 0.02 Intolerant 0.863 Possibly damaging −1.251 Neutral
rs773581866 Arg [R]/Gly [G] 0 Intolerant 0.008 Benign −0.341 Neutral
rs770126214 Leu [L]/Ile [I] 0.09 Tolerant 0.032 Benign −1.069 Neutral
rs1374154306 Leu [L]/Gln [Q] 0 Intolerant 0.853 Possibly damaging −4.116 Deleterious
rs748588515 Leu [L]/Phe [F] 0 Intolerant 0.914 Probably damaging −3.922 Deleterious
rs757087261 Phe [F]/Ile [I] 0.08 Tolerant 0.219 Benign −4.242 Deleterious
rs777020657 Phe [F]/Cys [C] 0.03 Intolerant 0.359 Benign −6.281 Deleterious
rs777020657 F (Phe) > S (Ser) 0 Intolerant 0.936 Probably damaging −6.607 Deleterious
rs769089021 Ser [S]/Asn [N] 0 Intolerant 0.999 Probably damaging −2.946 Deleterious
rs780381836 Arg [R]/Gly [G] 0.01 Intolerant 0.548 Possibly damaging −6.565 Deleterious
rs1480881050 Tyr [Y]/His [H] 0 Intolerant 0.903 Possibly damaging −4.446 Deleterious
rs1250722271 Tyr [Y]/His [H] 0 Intolerant 0.928 Probably damaging −3.256 Deleterious
rs1158317020 Tyr [Y]/Phe [F] 0.06 Tolerant 0.02 Benign −1.172 Neutral
rs867996396 Ile [I]/Asn [N] 0 Intolerant 0.958 Probably damaging −6.497 Deleterious
rs867996396 Ile [I] / Thr [T] 0 Intolerant 0.925 Probably damaging −4.799 Deleterious
rs536261161 Lys [K]/Asn [N] 1 Tolerant 0.004 Benign 0.309 Neutral
rs745373269 Asp [D]/Asn [N] 1 Tolerant 0.003 Benign 0.872 Neutral
rs745373269 Asp [D]/His [H] 0.05 Tolerant 0.637 Possibly damaging −1.072 Neutral
rs1367431424 Glu [E]/Ala [A] 0.2 Tolerant 0.155 Benign −3.915 Deleterious
rs865881030 Glu [E]/Lys [K] 0 Intolerant 0.377 Benign −3.096 Deleterious
rs778607566 Glu [E]/Gly [G] 0 Intolerant 0.944 Probably damaging −5.575 Deleterious
rs1309254226 Glu [E]/Asp [D] 0.03 Intolerant 0.247 Benign −2.277 Neutral
rs777225980 Ser [S]/Arg [R] 0.07 Tolerant 0.689 Possibly damaging −2.569 Deleterious
rs76026576 Leu [L]/Phe [F] 0 Intolerant 0.998 Probably damaging −3.757 Deleterious
rs1490504926 Asp [D]/Asn[N] 0.51 Tolerant 0.005 Benign −0.126 Neutral
rs935009475 Asp [D]/Glu [E] 0.06 Tolerant 0.434 Benign −3.438 Deleterious
rs774721090 DD (AspAsp) / D (Asp) −6.952 Deleterious
rs140285191 Asp [D]/Asn[N] 0 Intolerant 0.516 Possibly damaging −4.047 Deleterious
rs140285191 Asp [D]/Tyr [Y] 0 Intolerant 0.981 Probably damaging −7.312 Deleterious
rs754932741 Met [M]/Ile [I] 0 Intolerant 0.17 Benign −3.506 Deleterious
rs750579210 Arg [R]/Gly [G] 0 Intolerant 0.579 Possibly damaging −4.146 Deleterious
rs1304842107 Lys [K]/Gln [Q] 0.07 Tolerant 0.166 Benign −0.767 Neutral
rs765426962 Lys [K]/Thr [T] 0.13 Tolerant 0.065 Benign −2.692 Deleterious
rs761756532 Lys [K]/Asn [N] 0.09 Tolerant 0.036 Benign −1.633 Neutral
rs1329237779 Glu [E]/Lys [K] 1 Tolerant 0.03 Benign −0.266 Neutral
rs1384542256 Glu [E]/Ala [A] 0.64 Tolerant 0.055 Benign −3.333 Deleterious
rs776912318 Ser [S]/Arg [R] 1 Tolerant 0.009 Benign −0.133 Neutral
rs776912318 Ser [S]/Cys [C] 0.02 Intolerant 0.031 Benign −2.646 Deleterious
rs764161243 Lys [K]/Thr [T] 0.05 Tolerant 0.133 Benign −4.412 Deleterious
rs780873643 Val [V]/Gly [G] 0 Intolerant 0.943 Probably damaging −6.041 Deleterious
rs775691314 Ser [S]/Cys [C] 0 Intolerant 0.984 Probably damaging −3.556 Deleterious
rs772619265 Ile [I]/Val [V] 0.4 Tolerant 0.02 Benign −0.515 Neutral
rs760061096 Ile [I]/Lys [K] 0 Intolerant 0.824 Possibly damaging −5.896 Deleterious
rs749789723 Leu [L]
rs1205719797 Leu [L]/His [H] 0 Intolerant 0.999 Probably damaging −6.482 Deleterious
rs1364855365 Thr [T]/Ser [S] 0.58 Tolerant 0.065 Benign −0.827 Neutral
rs368432491 Asn [N]/Ser [S] 1 Tolerant 0.006 Benign 1.283 Neutral
rs182778895 Ser [S]/Pro [P] 1 Tolerant 0.004 Benign 1.098 Neutral
rs777540740 Ser [S]/Cys [C] 0.06 Tolerant 0.031 Benign −2.516 Deleterious
rs769325995 Tyr [Y]/His [H] 0.11 Tolerant 0.32 Benign −4.3 Deleterious
rs374492763 Arg [R]/Gln [Q] 0.04 Intolerant 0.771 Possibly damaging −3.702 Deleterious
rs374492763 Arg [R]/Leu [L] 0 Intolerant 0.906 Possibly damaging −6.535 Deleterious
rs938526894 Leu [L]/Pro [P] 0 Intolerant 0.811 Possibly damaging −4.885 Deleterious
rs1312418962 Met [M]/Thr [T] 0.03 Intolerant 0.411 Benign −3.131 Deleterious
rs1421580115 Val [V]/Met [M] 0.04 Intolerant 0.007 Benign 0.763 Neutral
rs1324205444 Ala [A]/Thr [T] 0 Intolerant 0.842 Possibly damaging −0.976 Neutral
rs1324205444 Ala [A]/Ser [S] 1 Tolerant 0.138 Benign 1.321 Neutral
rs780067980 Gly [G]/Arg [R] 0 Intolerant 1 Probably damaging −7.439 Deleterious
rs369101584 Asn [N]/Ser [S] 0.01 Intolerant 0.919 Probably damaging −4.649 Deleterious
rs757366672 Gly [G]/Cys [C] 0 Intolerant 0.507 Possibly damaging −2.067 Neutral
rs767670296 Ile [I]/Asn [N] 0 Intolerant 0.99 Probably damaging −6.223 Deleterious
rs1272816101 Ile [I]/Met [M] 0 Intolerant 0.985 Probably damaging −2.411 Neutral
rs759952425 Tyr [Y]/His [H] 0 Intolerant 0.986 probaly damaging −4.763 Deleterious
rs751917665 Thr [T]/Met [M] 0.03 Intolerant 0.075 Benign −2.321 Neutral
rs1441375275 Ala [A]/Thr [T] 0 Intolerant 0.955 Probably damaging −3.749 Deleterious
rs763345848 Gly [G]/Asp [D] 0 Intolerant 0.96 Probably damaging −6.283 Deleterious
rs1461795294 Ser [S]/Gly [G] 0.47 Tolerant 0.013 Benign −1.028 Neutral
rs773717998 Thr [T]/Asn [N] 0 Intolerant 0.986 Probably damaging −4.736 Deleterious
rs1162318193 Ile [I]/Thr [T] 0 Intolerant 0.775 Possibly damaging −4.7 Deleterious
rs1050103029 Val [V]/Ala [A] 1 Tolerant 0.071 Benign 0.25 Neutral
rs764683908 Gly [G]/Asp [D] 0 Intolerant 1 Probably damaging −6.631 Deleterious
rs776435170 Ala [A]/Thr [T] 0.02 Intolerant 0.032 Benign −0.943 Neutral
rs1236921754 Ala [A]/Val [V] 1 Tolerant 0.006 Benign 1.67 Neutral
rs746863503 Met [M]/Arg[R] 0 Intolerant 0.034 Benign −1.288 Neutral
rs775407568 Met [M]/Ile [I] 0.06 Tolerant 0.001 Benign −0.367 Neutral
rs771855037 Ala [A]/Thr [T] 0.01 Intolerant 0.102 Benign −0.618 Neutral
rs140815551 Val [V]/Ile [I] 0.03 Intolerant 0.047 Benign −0.733 Neutral
rs1348497054 Ser [S]/Cys [C] 0 Intolerant 0.929 Probably damaging −4.52 Deleterious
rs1469035471 Val [V]/Leu [L] 1 Tolerant 0.105 Benign 0.367 Neutral
rs372845210 Leu [L]/Ile [I] 0.04 Intolerant 0.817 Possibly damaging −1.156 Neutral
rs372845210 Leu [L]/Phe [F] 0 Intolerant 0.94 Probably damaging −3.045 Deleterious
rs1380054283 Glu [E]/Gln [Q] 0 Intolerant 0.984 Probably damaging −2.416 Neutral
rs999185720 Glu [E]/Asp [D] 0.31 Tolerant 0.162 Benign −2.169 Neutral
rs745619267 Lys [K]/Asn [N] 0 Intolerant 0.821 Possibly damaging −2.418 Neutral
rs76362149 Ala [A]/Ser [S] 0 Intolerant 0.457 Possibly damaging −2.448 Neutral
rs781225543 Arg [R]/Gln [Q] 0 Intolerant 1 Probably damaging −3.368 Deleterious
rs1321655963 Arg [R]/Cys [C] 0 Intolerant 0.998 Probably damaging −6.914 Deleterious
rs755000812 Arg [R]/His [H] 0 Intolerant 0.996 Probably damaging −4.126 Deleterious
rs1223071449 Phe [F]/Leu [L] 0.14 Tolerant 0.004 Benign −2.507 Deleterious
rs1430684701 Leu [L]/Pro [P] 0 Intolerant 0.988 Probably damaging −5.765 Deleterious
rs747262541 Ser [S]/Asn [N] 0.01 Intolerant 0.361 Benign −1.303 Neutral
rs868182136 Gly [G]/Glu [E] 0 Intolerant 0.99 Probably damaging −6.873 Deleterious
rs780255530 Met [M]/Val [V] 0 Intolerant 0.491 Possibly damaging −3.484 Deleterious
rs758699271 Met [M]/Ile [I] 0 Intolerant 0.612 Possibly damaging −3.451 Deleterious
rs946622803 Phe [F]/Leu [L] 0.49 Tolerant 0.006 Benign 0.13 Neutral
rs1381085405 Phe [F]/Tyr [Y] 0.23 Tolerant 0.652 Possibly damaging −0.543 Neutral
rs1381085405 Phe [F]/Ser [S] 0.41 Tolerant 0.063 Benign 0.376 Neutral
rs750782646 Ile [I]/Asn [N] 0 Intolerant 0.811 Possibly damaging −4.874 Deleterious
rs765728439 Met [M]/Thr [T] 0 Intolerant 0.403 Benign −5.185 Deleterious
rs757805176 Gly [G]/Arg [R] 0 Intolerant 0.752 Possibly damaging −2.96 Deleterious
rs757805176 Gly [G]/Arg [R] 0 Intolerant 0.752 Possibly damaging −2.96 Deleterious
rs1199637811 Val [V]/Gly [G] 0.19 Tolerant 0.027 Benign −2.318 Neutral
rs121909747 Leu [L]/Arg [R] 0 Intolerant 0.947 Probably damaging −4.842 Deleterious
rs 121,909,747 Leu [L] / Pro [P] 0.01 Intolerant 0.618 Possibly damaging −5.813 Deleterious
rs760200790 Leu [L]/Arg [R] 0.6 Tolerant 0.139 Benign −1.45 Neutral
rs766191732 Phe [F]/Leu [L] 0.69 Tolerant 0.002 Benign −1.523 Neutral
rs1464417991 Ser [S]/Pro [P] 1 Tolerant 0.005 Benign −0.341 Neutral
rs762668792 Val [V]/Glu [E] 0 Intolerant 0.866 Possibly damaging −5.082 Deleterious
rs1457657980 Met [M]/Val [V] 0.27 Tolerant 0.03 Benign −0.744 Neutral
rs1161394690 M (Met) > MM(MetMet)
rs374702599 Ile [I]/Thr [T] 0.18 Tolerant 0.002 Benign −0.852 Neutral
rs1419532672 Ile [I]/Val [V] 0.19 Tolerant 0.139 Benign −0.555 Neutral
rs2229608 Ile [I]/Thr [T] 0.21 Tolerant 0.401 Benign −3.639 Deleterious
rs760729620 Phe [F]/Ser [S] 0 Intolerant 0.861 Possibly damaging −7.529 Deleterious
rs140791627 Ser [S]/Cys [C] 0.05 Tolerant 0.082 Benign −2.035 Neutral
rs746136121 Phe [F]/Leu [L] 0.06 Tolerant 0.38 Benign −3.987 Deleterious
rs1353890919 Phe [F]/Cys [C] 0 Intolerant 1 Probably damaging −7.57 Deleterious
rs966424064 Ile [I]/Thr [T] 0 Intolerant 0.206 Benign −4.159 Deleterious
rs779212294 Ile [I]/Met [M] 0.08 Tolerant 0.643 Possibly damaging −2.032 Neutral
rs121909744 Pro [P]/Arg [R] 0 Intolerant 0.998 Probably damaging −8.516 Deleterious
rs121909744 Pro [P]/Leu [L] 0 Intolerant 0.994 Probably damaging −9.463 Deleterious
rs1309197020 Ile [I]/Met [M] 0 Intolerant 1 Probably damaging −2.838 Deleterious
rs1309197020 I (Ile) / I (Ile) 1 Tolerant 0 Neutral
rs749661374 Met [M]/Val [V] 0.01 Intolerant 0.004 Benign 0.655 Neutral
rs778490867 Met [M]/Thr [T] 0 Intolerant 0.016 Benign −2.558 Deleterious
rs28928874 Val [V]/Glu [E] 0 Intolerant 0.976 Probably damaging −5.619 Deleterious
rs367980651 Arg [R]/Cys [C] 0 Intolerant 0.983 Probably damaging −7.42 Deleterious
rs75144723 Arg [R]/His [H] 0 Intolerant 0.986 Probably damaging −4.632 Deleterious
rs754405476 Ala [A]/Thr [T] 0 Intolerant 0.992 Probably damaging −3.706 Deleterious
rs1379813904 Ala [A]/Glu [E] 0 Intolerant 0.987 Probably damaging −4.592 Deleterious
rs751226875 Ile [I]/Thr [T] 0 Intolerant 0.678 Possibly damaging −3.063 Deleterious
rs762675284 Ala [A]/Ser [S] 0.07 Tolerant 0.665 Possibly damaging −1.839 Neutral
rs1262058831 Ala [A]/Val [V] 0 Intolerant 0.99 Probably damaging −3.433 Deleterious
rs758246412 Ala [A]/Glu [E] 0.02 Intolerant 0.515 Possibly damaging −2.432 Neutral
rs1203908311 Asn [N]/Ser [S] 0 Intolerant 0.992 Probably damaging −4.589 Deleterious
rs765196886 Ile [I]/Leu [L] 0.59 Tolerant 0.009 Benign −0.308 Neutral
rs761784655 Ile [I]/Thr [T] 0 Intolerant 0.213 Benign −3.564 Deleterious
rs776395971 Val [V]/Ala [A] 0 Intolerant 0.895 Possibly damaging −3.625 Deleterious
rs1238600269 Ala [A]/Thr [T] 0 Intolerant 0.219 Benign −2.469 Neutral
rs1418589512 Cys [C]/Arg [R] 0.13 Tolerant 0.532 Possibly damaging −4.842 Deleterious
rs759480075 Tyr [Y]/His [H] 0.15 Tolerant 0.976 Probably damaging −3.381 Deleterious
rs771274850 Ile [I]/Thr [T] 0.01 Intolerant 0.653 Possibly damaging −2.456 Neutral
rs749710583 Ala [A]/Glu [E] 0.75 Tolerant 0.025 Benign −1.512 Neutral
rs749710583 Ala [A]/Val [V] 0.18 Tolerant 0.025 Benign −2.403 Neutral
rs774542648 Gly [G]/Arg [R] 0 Intolerant 0.734 Possibly damaging −7.25 Deleterious
rs1272353608 Pro [P]/His [H] 0 Intolerant 0.598 Possibly damaging −5.957 Deleterious
rs1381049817 Tyr [Y]/Cys [C] 0 Intolerant 0.439 Benign −8.015 Deleterious
rs1336322605 Phe [F]/Leu [L] 0.67 Tolerant 0.002 Benign 1.022 Neutral
rs140138702 Leu [L]/Val [V] 0.26 Tolerant 0.085 Benign −0.015 Neutral
rs770197371 Leu [L]/Arg [R] 0 Intolerant 0.944 Probably damaging −4.636 Deleterious
rs748401954 Phe [F]/Ser [S] 0 Intolerant 0.999 Probably damaging −7.315 Deleterious
rs374342938 Gly [G]/Ala [A] 0.15 Tolerant 0.02 Benign 0.329 Neutral
rs769037887 Val [V]/Met [M] 0.01 Intolerant 0.216 Benign 0.077 Neutral
rs556023421 Phe [F]/Leu [L] 0 Intolerant 0.919 Probably damaging −5.436 Deleterious
rs5397 Leu [L]/Val [V] 0.41 Tolerant 0.04 Benign −0.284 Neutral
rs5398 Phe [F]/Leu [L] 0 Intolerant 0.424 Benign −5.276 Deleterious
rs757137603 Thr [T]/Ile [I] 0.09 Tolerant 0.12 Benign −4.225 Deleterious
rs1441249949 Phe [F]/ Ile [I] 0 Intolerant 0.616 Possibly damaging −4.39 Deleterious
rs1195253424 Val [V]/Ile [I] 0 Intolerant 0.971 Probably damaging −0.908 Neutral
rs753575081 Pro [P]/Thr [T] 0 Intolerant 0.994 Probably damaging −7.274 Deleterious
rs777806589 Lys [K]/Arg [R] 0.38 Tolerant 0.601 Possibly damaging −1.518 Neutral
rs766600474 Ser [S]/Thr [T] 1 Tolerant 0.104 Benign 1.006 Neutral
rs766600474 Ser [S]/Ala [A] 0 Intolerant 0.304 Benign −1.65 Neutral
rs1379944645 Glu [E]/Lys [K] 0.04 Intolerant 0.279 Benign −3.223 Deleterious
rs1353603250 Glu [E]/Gln [Q] 0.19 Tolerant 0.759 Possibly damaging −2.031 Neutral
rs1446857276 Glu [E]/Asp [D] 0.31 Tolerant 0.405 Benign −0.5 Neutral
rs1283734332 Ile [I]/Thr [T] 0 Intolerant 0.999 Probably damaging −4.518 Deleterious
rs1445660295 Ala [A]/Val [V] 0.02 Intolerant 0.444 Benign −3.184 Deleterious
rs201797691 Ala [A]/Thr [T] 0.06 Tolerant 0.566 Possibly damaging −1.562 Neutral
rs201797691 Ala [A]/Pro [P] 0.03 Intolerant 0.979 Probably damaging −2.518 Deleterious
rs200160167 Ala [A]/Glu [E] 0.05 Tolerant 0.302 Benign −1.482 Neutral
rs200160167 Ala [A]/Val [V] 0.03 Intolerant 0.566 Possibly damaging −2.596 Deleterious
rs762305192 Phe [F]/Leu [L] 0 Intolerant 0.866 Possibly damaging −5.144 Deleterious
rs776826621 Lys [K]/Asn [N] 0.2 Tolerant 0.005 Benign −1.549 Neutral
rs5399 Lys [K]/Asn [N] 0.41 Tolerant 0.004 Benign −2.272 Neutral
rs1412427073 Gly [G]/Ser [S] 0.28 Tolerant 0.004 Benign −1.628 Neutral
rs966895511 Ala [A]/Ser [S] 0.83 Tolerant 0.004 Benign −0.449 Neutral
rs1199349184 Ala [A]/Val [V] 0.24 Tolerant 0.004 Benign −1.611 Neutral
rs374630641 Arg [R]/Ser [S] 0.94 Tolerant 0.001 Benign 0.45 Neutral
rs771586150 Pro [P]/Gln [Q] 0.47 Tolerant 0.007 Benign −1.564 Neutral
rs776597156 Lys [K]/Asn[N] 0.04 Intolerant 0.017 Benign −1.772 Neutral
rs770462591 Ala [A]/Asp [D] 0.41 Tolerant 0.002 Benign −1.217 Neutral
rs770462591 Ala [A]/Val [V] 0.16 Tolerant 0.007 Benign −1.309 Neutral
rs141574520 Phe [F]/Tyr [Y] 1 Tolerant 0.003 Benign 0.369 Neutral
rs147959014 Gly [G]/Glu [E] 0.01 Intolerant 0.104 Benign −2.153 Neutral
rs752687355 Glu [E]/Gly[G] 0.03 Intolerant 0.009 Benign −2.391 Neutral
rs781215842 Thr [T]/Ser [S] 0.82 Tolerant 0.004 Benign 0.326 Neutral
rs758607933 Val[V]/Met[M] 0 Intolerant 0.004 Benign −1.155 Neutral

Variants with tolerance index ≤ 0.05 score of SIFT was considered as deleterious while others are taken to be tolerant. By PolyPhen, the variations with probabilistic score above 0.85 and 0.15 were considered to be “Probably damaging” and “possibly damaging” respectively while all the resting were categorized to be “Benign”. Provean score was equal to or below −2.5 it may be considered as deleterious and if the score was above −2.5, it was considered as neutral.

3.5

3.5 Analysis of nsSNPS using PolyPhen

To forecast the effects of function and structure 293 nsSNPs lying in the coding region of GLUT2 protein, PolyPhen-2 server was used. It permits three types of prediction score which is based on a “Sensitivity” as well as “Specificity”. Three prediction types are given by PolyPhen benign, possibly damaging or probably damaging. Out of 293 nsSNPs, 165 were considered to be benign. 65 were predicted to be possibly damaging and 77 were considered to be probably damaging (Table 2).

3.6

3.6 Analysis of SNPs using PROVEAN

PROVEAN gave score to predict neutral and deleterious effect of 293 nsSNPs present in coding region of GLUT2 protein. Score equal to or below −2.5 was considered as deleterious and above −2.5, as neutral. Out of 293 nsSNPs, 162 were predicted to be neutral and 138 were considered to be deleterious. It also gave the results of inframe deletion and insertion. Out of 4 inframe deletion 2 (rs772999215 and rs774721090) were shown to be deleterious 3 SNPs were inframe insertion (rs1161394690), (rs1463507753), (rs749789723) and no results were found for them (Table 2).

3.7

3.7 Analysis of nsSNPS using SNPeffect

The SNPeffect server was used to predict the effect of molecular phenotype of nsSNPs found in coding region of GLUT2 protein. Effect of 293 nsSNPs on aggregation tendency, amyloid propensity and chaperon binding tendency was specified by dTANGO, dWALTZ and dLIMBO score. Two significant effects, intrinsic aggregation propensity and protein stability were shown. In a protein sequence, aggregation propensity was identified by dTANGO. Out of 293 nsSNPs, 61 were detected to decrease the aggregation propensity, 27 to increase the aggregation propensity while 211 had no effect on aggregation propensity. dWALTZ indicated the score of amyloid propensity. 23 nsSNPs were shown to increase the amyloid propensity, 16 decreased the amyloid propensity and 257 had no effect on the amyloid propensity. According to dLIMBO, the chaperon binding tendency was given. None of them had any effect on chaperon binding tendency (Table 3).

Table 3 Analysis of nsSNPs by SNPeffect in coding region of human GLUT2 protein.
dbSNP rs#cluster id Proteinresidue dTANGO Aggregationtendency dWALTZ Amyloidpropensity dLIMBO Chaperone bindingtendency
rs759495940 Met [M]/Ile [I] 0 No effect 0 No effect 0 No effect
rs773205789 Thr [T]/Pro [P] 0 No effect 0 No effect 0 No effect
rs200073044 Asp [D]/His [H] −101 Decrease 0.76 No effect 0 No effect
rs1372689853 Lys [K]/Glu [E] −110.2 Decreases −0.49 No effect 0 No effect
rs767313610 Val [V]/Ile [I] −5.8 No effect 0 No effect 0 No effect
rs369700669 Thr [T]/Asn [N] −109.6 Decreases 0.01 No effect 0 No effect
rs1481905618 Phe [F]/Leu [L] −1.1 No effect 0.12 No effect 0 No effect
rs1247912820 Thr [T]/Asn [N] −9.9 No effect 0.97 No effect 0 No effect
rs1247912820 Thr [T]/Ser [S] −2.7 No effect 0.34 No effect 0 No effect
rs372441014 Val [V]/Leu [L] −0.5 No effect 0.12 No effect 0 No effect
rs766364438 Ile [I]/Thr [T] −19.8 No effect 0.96 No effect 0 No effect
rs867315854 Ala [A]/Thr [T] −5.6 No effect 0.04 No effect 0 No effect
rs761992056 Gly [G]/Asp [D] −66 Decreases 2.67 No effect 0 No effect
rs369781481 Phe [F]/Leu [L] –22.4 No effect 0.12 No effect 0 No effect
rs1409436045 Phe [F]/Tyr [Y] −8.7 No effect 0.21 No effect 0 No effect
rs1049223265 Ile [I]/Thr [T] 0 No effect −0.09 No effect 0 No effect
rs1437312005 Gly [G]/Ser [S] 0 No effect 0.76 No effect 0 No effect
rs1437312005 Gly [G]/Arg [R] 0 No effect −0.09 No effect 0 No effect
rs775531825 Asn [N]/Ser [S] 0.1 No effect −0.08 No effect 0 No effect
rs143528640 Ala [A]/Thr [T] 0 No effect 0 No effect 0 No effect
rs746158263 Pro [P]/Thr [T] 4 No effect −0.02 No effect 0 No effect
rs1158195535 Gln [Q]/Lys [K] −4.3 No effect −559.66 Decreases 0 No effect
rs1158195535 Gln [Q]/Glu [E] 11 No effect −62.94 Decreases 0 No effect
rs1451394300 Val [V]/Ile [I] −0.9 No effect −116.97 Decreases 0 No effect
rs1477523180 Ile [I]/Leu [L] −2.5 No effect −3.89 No effect 0 No effect
rs1360464436 Ile [I]/Lys [K] −4.3 No effect −417.77 Decreases 0 No effect
rs1176350402 Ile [I]/Thr [T] −4.3 No effect −571.42 Decreases 0 No effect
rs758670698 Arg [R]/Ile [I] 110.7 Increases −0.73 No effect 0 No effect
rs760618624 His [H]/Tyr [Y] 1.1 No effect 0 No effect 0 No effect
rs775791143 Val [V]/Ile [I] 0 No effect 0.01 No effect 0 No effect
rs149108283 Val [V]/Asp [D] 1.7 No effect −0.72 No effect 0 No effect
rs149108283 Val [V]/Ala [A] 0 No effect 0.01 No effect 0 No effect
rs1159338702 Gly [G]/Ser [S] 0 No effect 0.02 No effect 0 No effect
rs561765982 Val [V]/Ile [I] 0 No effect 0 No effect 0 No effect
rs983907950 Pro [P]/Ser [S] 24.1 No effect −0.27 No effect 0 No effect
rs1211075508 Leu [L]/Pro [P] 0 No effect 0.23 No effect 0 No effect
rs1311902495 Asp [D]/Asn [N] −1.9 No effect 1.14 No effect 0 No effect
rs1311902495 Asp [D]/Tyr [Y] −1.9 No effect 1.01 No effect 0 No effect
rs771477447 Arg [R]/Gly [G] 0.7 No effect 0.07 No effect 0 No effect
rs145210664 Arg [R]/Gln [Q] 0.6 No effect −0.52 No effect 0 No effect
rs546539032 Lys [K]/Asn [N] 2.3 No effect 0.11 No effect 0 No effect
rs747555903 Val [V]/Ile [I] −0.1 No effect −58.27 Decreases 0 No effect
rs977284195 Ile [I]/Thr [T] −1 No effect 0.02 No effect 0 No effect
rs780903829 Ile [I]/Met [M] −1 No effect 0.01 No effect 0 No effect
rs1373290524 Ser [S]/Thr [T] 1 No effect 0 No effect 0 No effect
rs1310901426 Thr [T]/Ala [A] −0.1 No effect 0.02 No effect 0 No effect
rs1354126805 Thr [T]/Arg [R] 1.6 No effect −0.03 No effect 0 No effect
rs754585542 Asp [D]/Asn [N] −1.9 No effect 0.76 No effect 0 No effect
rs1217666649 Asp [D]/Glu [E] 0 No effect 0.01 No effect 0 No effect
rs1391257598 Pro [P]/Thr [T] 0 No effect 0.33 No effect 0 No effect
rs7637863 Pro [P]/Leu [L] 6.5 No effect 7.11 No effect 0 No effect
rs779977931 Thr [T]/Lys [K] 0 No effect −0.35 No effect 0 No effect
rs1182852354 Ile [I]/Val [V] 0 No effect −0.44 No effect 0 No effect
rs750405382 Met [M]/Val [V] 3.5 No effect 0.26 No effect 0 No effect
rs1207297111 Asn [N]/Asp [D] 1.7 No effect −0.72 No effect 0 No effect
rs1342979475 Asn [N]/Thr [T] 0 No effect 0 No effect 0 No effect
rs1274084408 Pro [P]/Ala [A] 0 No effect 0 No effect 0 No effect
rs778655073 Pro [P]/Leu [L] 0 No effect 0 No effect 0 No effect
rs549263048 Trp [W]/Arg [R] 0 No effect 0 No effect 0 No effect
rs531049536 Trp [W]/Cys [C] 0.1 No effect −0.05 No effect 0 No effect
rs150851401 Glu [E]/Lys [K] −1.3 No effect 0.86 No effect 0 No effect
rs766762468 Thr [T]/Ser [S] −3.4 No effect 0.72 No effect 0 No effect
rs766762468 T (Thr) > I (Ile) 56.4 Increases −14.66 No effect 0 No effect
rs763255363 Ala [A]/Ser [S] −17.7 No effect 6.87 No effect 0 No effect
rs144715667 Ile [I]/Val [V] 12 No effect −212.15 Decreases 0 No effect
rs1415169647 Met [M]/Arg [R] −820.3 Decreases 227.06 Increases 0 No effect
rs1407375423 Trp [W]/Cys [C] −662.7 Decreases 200.31 Increases 0 No effect
rs1800572 Val [V]/Ile [I] −16 No effect 5.29 No effect 0 No effect
rs1800572 V (Val) > L (Leu) −161.8 Decreases 45.81 No effect 0 No effect
rs770135219 Val [V]/Ala [A] −382.9 Decreases 93.15 Increases 0 No effect
rs1399091893 Ala [A]/Val [V] 456.9 Increases −154.77 Decreases 0 No effect
rs1332764085 Val [V]/Ile [I] −12.4 No effect 3.22 No effect 0 No effect
rs5400 Thr [T]/Ile [I] 142.4 Increases −3.5 No effect 0 No effect
rs377238940 Ala [A]/Pro [P] −7.5 No effect −7.19 No effect 0 No effect
rs768407637 Gly [G]/Val [V] 395.8 Increases −4.57 No effect 0 No effect
rs753980727 Trp [W]/Cys [C] −4.8 No effect 0 No effect 0 No effect
rs746632604 Gly [G]/Ala [A] 3.2 No effect −0.03 No effect 0 No effect
rs772002572 Thr [T]/Ile [I] 3.6 No effect −0.02 No effect 0 No effect
rs1476520648 Ile [I]/Asn [N] 6.4 No effect 0.04 No effect 0 No effect
rs760201098 Ala [A]/Asp [D] 179.3 Increases −3.71 No effect 0 No effect
rs1267904495 Met [M]/Thr [T] −39.4 No effect 0.97 No effect 0 No effect
rs1212980167 Met [M]/Ile [I] 212.1 Increases −4.25 No effect 0 No effect
rs367856967 Val [V]/Ala [A] −393 Decreases 11.97 No effect 0 No effect
rs970550665 Ala [A]/Gly [G] −345 Decreases −1.75 No effect 0 No effect
rs775283150 Ile [I]/Phe [F] 13.1 No effect −3.23 No effect 0 No effect
rs913419413 Leu [L]/Arg [R] −1039.9 Decreases −4.86 No effect 0 No effect
rs771843187 Ser [S]/Pro [P] −962.7 Decreases 49.25 No effect 0 No effect
rs144125084 Val [V]/Leu [L] −119 Decreases 5.37 No effect 0 No effect
rs993833041 Val [V]/Ala [A] −567.9 Decreases 28.42 No effect 0 No effect
rs1300072764 Gly [G]/Glu [E] −327.2 Decreases 5.99 No effect 0 No effect
rs778548964 Leu [L]/Phe [F] 87.5 Increases −2.88 No effect 0 No effect
rs1016384738 Met [M]/Lys [K] −378.4 Decreases 11.06 No effect 0 No effect
rs770941010 Gly [G]/Arg [R] −228.7 Decreases 6.26 No effect 0 No effect
rs777718289 Gly [G]/Glu [E] 3.5 No effect −0.81 No effect 0 No effect
rs777718289 Gly [G]/Val [V] 0.6 No effect 0.19 No effect 0 No effect
rs372621339 Pro [P]/Arg [R] −2.6 No effect 1.25 No effect 0 No effect
rs747025551 Ile [I]/Thr [T] −254.4 Decreases −380.89 Decreases 0 No effect
rs376064965 Leu [L]/Phe [F] 90.6 Increases 99.92 Increases 0 No effect
rs1188886679 Ile [I]/Leu [L] −87.4 Decreases −29.47 No effect 0 No effect
rs1188886679 Ile [I]/Val [V] 9.3 No effect −467.67 Decreases 0 No effect
rs192720796 Ile [I]/Lys [K] −292.7 Decreases −470.84 Decreases 0 No effect
rs910976682 Ala [A]/Val [V] 190.3 Increases −165.8 Decreases 0 No effect
rs750836049 Gly [G]/Arg [R] −136.3 Decreases 37.18 No effect 0 No effect
rs1278964539 Arg [R]/Lys [K] −0.1 No effect −0.07 No effect 0 No effect
rs1231468128 Leu [L]/Gln [Q] −8 No effect −0.23 No effect 0 No effect
rs1445887606 Tyr [Y]/His [H] −9.1 No effect −6.28 No effect 0 No effect
rs1271546287 Ile [I]/Thr [T] −10.1 No effect −12.03 No effect 0 No effect
rs760095835 Gly [G]/Asp [D] −2.3 No effect −0.62 No effect 0 No effect
rs1335888503 Val [V]/Leu [L] 0 No effect −0.02 No effect 0 No effect
rs1293130515 Met [M]/Thr [T] 0 No effect −0.02 No effect 0 No effect
rs1019696977 Ile [I]/Val [V] 0 No effect −5.05 No effect 0 No effect
rs144822218 Gly [G]/Ser [S] 0 No effect 43.87 No effect 0 No effect
rs759047405 Gly [G]/Asp [D] 1.7 No effect −6.74 No effect 0 No effect
rs1441606652 Ala [A]/Val [V] 0 No effect 7.16 No effect 0 No effect
rs368626129 Ala [A]/Thr [T] 0 No effect 0.02 No effect 0 No effect
rs368626129 Ala [A]/Ser [S] 0 No effect 0.01 No effect 0 No effect
rs200213178 Ala [A]/Thr [T] −0.1 No effect 0.01 No effect 0 No effect
rs200213178 Ala [A]/Pro [P] −0.1 No effect 0 No effect 0 No effect
rs748052042 Leu [L]/Phe [F] 0.7 No effect 0 No effect 0 No effect
rs1412289847 Gly [G]/Ser [S] 0.1 No effect 0.02 No effect 0 No effect
rs776498787 Gly [G]/Asp [D] 0.4 No effect −0.61 No effect 0 No effect
rs779065938 Leu [L]/Val [V] 36.5 No effect 146.08 Increases 0 No effect
rs1469335096 Ala [A]/Thr [T] −20.5 No effect 4.53 No effect 0 No effect
rs771182536 Ile [I]/Asn [N] −603.7 Decreases 96.63 Increases 0 No effect
rs771182536 Ile [I]/Thr [T] −306.2 Decreases 63.05 Increases 0 No effect
rs121909741 Val [V]/Ile [I] −2.4 No effect −10.45 No effect 0 No effect
rs149460434 Thr [T]/Lys [K] 502 Increases 54.29 Increases 0 No effect
rs149460434 Thr [T]/Met [M] 14.7 No effect −16.93 No effect 0 No effect
rs1276756236 Leu [L]/Ile [I] 16.9 No effect −17.56 No effect 0 No effect
rs779591826 Ile [I]/Met [M] −147 Decreases 82.45 Increases 0 No effect
rs1262860274 Ile [I]/Thr [T] −148.5 Decreases 77.8 Increases 0 No effect
rs1186359171 Gly [G]/Ser [S] 12.2 No effect −13.3 No effect 0 No effect
rs1215469128 Leu [L]/Ser [S] 0.7 No effect −9.46 No effect 0 No effect
rs1347267249 Asn [N]/His [H] 1 No effect −3.73 No effect 0 No effect
rs573292685 Asn [N]/Ser [S] 0.9 No effect −5.01 No effect 0 No effect
rs764799427 Asp [D]/Val [V] 905.2 Increases −37.64 No effect 0 No effect
rs1380319602 Ile [I]/Asn [N] −54 Decreases −78.29 Decreases 0 No effect
rs760641937 Gly [G]/Ala [A] 209.4 Increases −34.8 No effect 0 No effect
rs1413841367 Leu [L]/Pro [P] −45.1 No effect 8.09 No effect 0 No effect
rs771075989 Val [V]/Met [M] −2.4 No effect 0.47 No effect 0 No effect
rs773581866 Arg [R]/Gly [G] 174.1 Increases −49 No effect 0 No effect
rs770126214 Leu [L]/Ile [I] 60.4 Increases −3.97 No effect 0 No effect
rs1374154306 Leu [L]/Gln [Q] −491.6 Decreases 317.25 Increases 0 No effect
rs748588515 Leu [L]/Phe [F] 15.7 No effect 32.66 No effect 0 No effect
rs757087261 Phe [F]/Ile [I] −4.5 No effect −9.69 No effect 0 No effect
rs777020657 Phe [F]/Cys [C] −264.3 Decreases 1.76 No effect 0 No effect
rs777020657 F (Phe) > S (Ser) −295.4 Decreases 40.37 No effect 0 No effect
rs769089021 Ser [S]/Asn [N] −0.1 No effect 0 No effect 0 No effect
rs780381836 Arg [R]/Gly [G] 4.2 No effect 147.36 Increases 0 No effect
rs1480881050 Tyr [Y]/His [H] −1.6 No effect −8.07 No effect 0 No effect
rs1250722271 Tyr [Y]/His [H] −2.3 No effect −8.13 No effect 0 No effect
rs1158317020 Tyr [Y]/Phe [F] 7.6 No effect −6.38 No effect 0 No effect
rs867996396 Ile [I]/Asn [N] −2.3 No effect −8.12 No effect 0 No effect
rs867996396 I (Ile) > T (Thr) −2.3 No effect −8.19 No effect 0 No effect
rs536261161 Lys [K]/Asn [N] 62.3 Increases 385.31 Increases 0 No effect
rs745373269 Asp [D]/Asn [N] −4.2 No effect 0.87 No effect 0 No effect
rs745373269 Asp [D]/His [H] −4.2 No effect 1.41 No effect 0 No effect
rs1367431424 Glu [E]/Ala [A] 11.5 No effect 0.95 No effect 0 No effect
rs865881030 Glu [E]/Lys [K] −1.8 No effect 1.2 No effect 0 No effect
rs778607566 Glu [E]/Gly [G] 4 No effect 1.31 No effect 0 No effect
rs1309254226 Glu [E]/Asp [D] −0.1 No effect 0.45 No effect 0 No effect
rs777225980 Ser [S]/Arg [R] −0.2 No effect −0.6 No effect 0 No effect
rs76026576 Leu [L]/Phe [F] 0 No effect 0.07 No effect 0 No effect
rs1490504926 Asp [D]/Asn [N] −1.9 No effect 0.74 No effect 0 No effect
rs935009475 Asp [D]/Glu [E] 0 No effect 0.01 No effect 0 No effect
rs140285191 Asp [D]/Asn [N] −1.9 No effect 1.25 No effect 0 No effect
rs140285191 Asp [D]/Tyr [Y] −1.9 No effect 2.54 No effect 0 No effect
rs754932741 Met [M]/Ile [I] 0 No effect 0.08 No effect 0 No effect
rs750579210 Arg [R]/Gly [G] −0.2 No effect 0.03 No effect 0 No effect
rs1304842107 Lys [K]/Gln [Q] −0.2 No effect 0.03 No effect 0 No effect
rs765426962 Lys [K]/Thr [T] −0.2 No effect 0.03 No effect 0 No effect
rs761756532 Lys [K]/Asn [N] −0.2 No effect 0.03 No effect 0 No effect
rs1329237779 Glu [E]/Lys [K] −1.9 No effect 0.76 No effect 0 No effect
rs1384542256 Glu [E]/Ala [A] −1.9 No effect 0.76 No effect 0 No effect
rs776912318 Ser [S]/Arg [R] −1.3 No effect −0.29 No effect 0 No effect
rs776912318 Ser [S]/Cys [C] 0.1 No effect −0.04 No effect 0 No effect
rs764161243 Lys [K]/Thr [T] 123 Increases −19.4 No effect 0 No effect
rs780873643 Val [V]/Gly [G] −69.1 Decreases 4.31 No effect 0 No effect
rs775691314 Ser [S]/Cys [C] 30.7 No effect −9.87 No effect 0 No effect
rs772619265 Ile [I]/Val [V] 10.1 No effect 97.69 Increases 0 No effect
rs760061096 Ile [I]/Lys [K] −201.9 Decreases −43.38 No effect 0 No effect
rs1205719797 Leu [L]/His [H] −203 Decreases −200.41 Decreases 0 No effect
rs1364855365 Thr [T]/Ser [S] −54.4 Decreases 69.79 Increases 0 No effect
rs368432491 Asn [N]/Ser [S] 5.5 No effect −2.26 No effect 0 No effect
rs182778895 Ser [S]/Pro [P] −4.4 No effect −0.59 No effect 0 No effect
rs777540740 Ser [S]/Cys [C] 0.9 No effect 0.46 No effect 0 No effect
rs769325995 Tyr [Y]/His [H] −0.9 No effect −0.61 No effect 0 No effect
rs374492763 Arg [R]/Gln [Q] 0.6 No effect 0.05 No effect 0 No effect
rs374492763 Arg [R]/Leu [L] 0.5 No effect 0.06 No effect 0 No effect
rs938526894 Leu [L]/Pro [P] −548.4 Decreases 0.15 No effect 0 No effect
rs1312418962 Met [M]/Thr [T] −36.1 No effect 0.01 No effect 0 No effect
rs1421580115 Val [V]/Met [M] −30.3 No effect 0.05 No effect 0 No effect
rs1324205444 Ala [A]/Thr [T] −4.9 No effect −0.03 No effect 0 No effect
rs1324205444 Ala [A]/Ser [S] −15 No effect −0.04 No effect 0 No effect
rs780067980 Gly [G]/Arg [R] −12.6 No effect 0.05 No effect 0 No effect
rs369101584 Asn [N]/Ser [S] 42.5 No effect −0.2 No effect 0 No effect
rs757366672 Gly [G]/Cys [C] 33.1 No effect −190.41 Decreases 0 No effect
rs767670296 Ile [I]/Asn [N] −470.3 Decreases −49.94 No effect 0 No effect
rs1272816101 Ile [I]/Met [M] −365.7 Decreases −30.37 No effect 0 No effect
rs759952425 Tyr [Y]/His [H] −553.7 Decreases −590.8 Decreases 0 No effect
rs751917665 Thr [T]/Met [M] 14.8 No effect −0.05 No effect 0 No effect
rs1441375275 Ala [A]/Thr [T] −2.3 No effect 0.02 No effect 0 No effect
rs763345848 Gly [G]/Asp [D] −8.9 No effect −0.68 No effect 0 No effect
rs1461795294 Ser [S]/Gly [G] −0.1 No effect 0 No effect 0 No effect
rs773717998 Thr [T]/Asn [N] −0.9 No effect 0.03 No effect 0 No effect
rs1162318193 Ile [I]/Thr [T] −61.4 Decreases 0 No effect 0 No effect
rs1050103029 Val [V]/Ala [A] −116.3 Decreases 0.03 No effect 0 No effect
rs764683908 Gly [G]/Asp [D] −148.2 Decreases 2.22 No effect 0 No effect
rs776435170 Ala [A]/Thr [T] −37.9 No effect 0.01 No effect 0 No effect
rs1236921754 Ala [A]/Val [V] 274.6 Increases 0 No effect 0 No effect
rs746863503 Met [M]/Arg [R] −234.8 Decreases 3.51 No effect 0 No effect
rs775407568 Met [M]/Ile [I] 86.5 Increases 0.83 No effect 0 No effect
rs771855037 Ala [A]/Thr [T] −1.1 No effect 0.01 No effect 0 No effect
rs140815551 Val [V]/Ile [I] −0.1 No effect 0.01 No effect 0 No effect
rs1348497054 Ser [S]/Cys [C] 0.2 No effect −0.05 No effect 0 No effect
rs1469035471 Val [V]/Leu [L] −0.2 No effect 0.16 No effect 0 No effect
rs372845210 Leu [L]/Ile [I] 0.5 No effect 0.06 No effect 0 No effect
rs372845210 Leu [L]/Phe [F] 0.5 No effect 0.03 No effect 0 No effect
rs1380054283 Glu [E]/Gln [Q] −16.6 No effect 0.77 No effect 0 No effect
rs999185720 Glu [E]/Asp [D] −0.1 No effect 0 No effect 0 No effect
rs745619267 Lys [K]/Asn [N] −10.2 No effect 0.03 No effect 0 No effect
rs76362149 Ala [A]/Ser [S] −0.1 No effect 0 No effect 0 No effect
rs781225543 Arg [R]/Gln [Q] 1.3 No effect −0.54 No effect 0 No effect
rs1321655963 Arg [R]/Cys [C] 10 No effect −10.88 No effect 0 No effect
rs755000812 Arg [R]/His [H] 8.8 No effect −10.45 No effect 0 No effect
rs1223071449 Phe [F]/Leu [L] −5 No effect −25.18 No effect 0 No effect
rs1430684701 Leu [L]/Pro [P] −10.5 No effect −27.2 No effect 0 No effect
rs747262541 Ser [S]/Asn [N] −3.6 No effect 46.65 No effect 0 No effect
rs868182136 Gly [G]/Glu [E] 286.1 Increases 249.54 Increases 0 No effect
rs780255530 Met [M]/Val [V] 63.2 Increases −24.52 No effect 0 No effect
rs758699271 Met [M]/Ile [I] 62.1 Increases −24.31 No effect 0 No effect
rs946622803 Phe [F]/Leu [L] −20.9 No effect 28.63 No effect 0 No effect
rs1381085405 Phe [F]/Tyr [Y] −39.4 No effect 54.3 Increases 0 No effect
rs1381085405 Phe [F]/Ser [S] −178.9 Decreases 280.03 Increases 0 No effect
rs750782646 Ile [I]/Asn [N] −318.3 Decreases 268.28 Increases 0 No effect
rs765728439 Met [M]/Thr [T] −3.8 No effect 14.75 No effect 0 No effect
rs757805176 Gly [G]/Arg [R] −191 Decreases 26.9 No effect 0 No effect
rs757805176 Gly [G]/Arg [R] −191 Decreases 26.9 No effect 0 No effect
rs1199637811 Val [V]/Gly [G] −117.4 Decreases 11.9 No effect 0 No effect
rs121909747 Leu [L]/Arg [R] −125.4 Decreases 11.4 No effect 0 No effect
rs 121,909,747 L (Leu) > P (Pro) −133.3 Decreases 12.33 No effect 0 No effect
rs760200790 Leu [L]/Arg [R] −62.3 Decreases 8.37 No effect 0 No effect
rs766191732 Phe [F]/Leu [L] −25.2 No effect 0.37 No effect 0 No effect
rs1464417991 Ser [S]/Pro [P] −94.9 Decreases 1.83 No effect 0 No effect
rs762668792 Val [V]/Glu [E] −565.8 Decreases 46.57 No effect 0 No effect
rs1457657980 Met [M]/Val [V] 23.2 No effect −2.74 No effect 0 No effect
rs374702599 Ile [I]/Thr [T] −72.2 Decreases 43.39 No effect 0 No effect
rs1419532672 Ile [I]/Val [V] −0.1 No effect −2.52 No effect 0 No effect
rs2229608 Ile [I]/Thr [T] 5.3 No effect −1.6 No effect 0 No effect
rs760729620 Phe [F]/Ser [S] −14.9 No effect −2.61 No effect 0 No effect
rs140791627 Ser [S]/Cys [C] 85.1 Increases −1.9 No effect 0 No effect
rs746136121 Phe [F]/Leu [L] −35.7 No effect 2.96 No effect 0 No effect
rs1353890919 Phe [F]/Cys [C] 4.5 No effect 5.85 No effect 0 No effect
rs966424064 Ile [I]/Thr [T] 0 No effect 0 No effect 0 No effect
rs779212294 Ile [I]/Met [M] 0 No effect 0 No effect 0 No effect
rs121909744 Pro [P]/Arg [R] 9.1 No effect −0.44 No effect 0 No effect
rs121909744 Pro [P]/Leu [L] −0.1 No effect 4.65 No effect 0 No effect
rs1309197020 Ile [I]/Met [M] −0.2 No effect −0.05 No effect 0 No effect
rs1309197020 I (Ile) > I (Ile) 0 No effect 0 No effect 0 No effect
rs749661374 Met [M]/Val [V] 230.5 Increases −18.16 No effect 0 No effect
rs778490867 Met [M]/Thr [T] −27.3 No effect 2.19 No effect 0 No effect
rs28928874 Val [V]/Glu [E] −56.9 Decreases –33.24 No effect 0 No effect
rs367980651 Arg [R]/Cys [C] 17.1 No effect −2.91 No effect 0 No effect
rs75144723 Arg [R]/His [H] 16.7 No effect −2.79 No effect 0 No effect
rs754405476 Ala [A]/Thr [T] −15.2 No effect −42.65 No effect 0 No effect
rs1379813904 Ala [A]/Glu [E] −158.8 Decreases −15.31 No effect 0 No effect
rs751226875 Ile [I]/Thr [T] −147.2 Decreases −53.16 Decreases 0 No effect
rs762675284 Ala [A]/Ser [S] −118.2 Decreases 48.11 No effect 0 No effect
rs1262058831 Ala [A]/Val [V] 346.5 Increases 54.41 Increases 0 No effect
rs758246412 Ala [A]/Glu [E] −113.4 Decreases 126.69 Increases 0 No effect
rs1203908311 Asn [N]/Ser [S] 90 Increases −44.34 No effect 0 No effect
rs765196886 Ile [I]/Leu [L] 18.3 No effect 38.73 No effect 0 No effect
rs761784655 Ile [I]/Thr [T] −138.3 Decreases 205.72 Increases 0 No effect
rs776395971 Val [V]/Ala [A] −96.7 Decreases 204.13 Increases 0 No effect
rs1238600269 Ala [A]/Thr [T] 10.6 No effect 20.07 No effect 0 No effect
rs1418589512 Cys [C]/Arg [R] −104.2 Decreases 339.43 Increases 0 No effect
rs759480075 Tyr [Y]/His [H] −83.6 Decreases −6.52 No effect 0 No effect
rs771274850 Ile [I]/Thr [T] −80 Decreases −6.87 No effect 0 No effect
rs749710583 Ala [A]/Glu [E] −69.6 Decreases −5.77 No effect 0 No effect
rs749710583 Ala [A]/Val [V] 142 Increases −15.87 No effect 0 No effect
rs774542648 Gly [G]/Arg [R] 6 No effect 0 No effect 0 No effect
rs1272353608 Pro [P]/His [H] −169.7 Decreases −11.73 No effect 0 No effect
rs1381049817 Tyr [Y]/Cys [C] 12.4 No effect −0.04 No effect 0 No effect
rs1336322605 Phe [F]/Leu [L] −0.3 No effect 0 No effect 0 No effect
rs140138702 Leu [L]/Val [V] 0 No effect 0 No effect 0 No effect
rs770197371 Leu [L]/Arg [R] −614.7 Decreases 0.4 No effect 0 No effect
rs748401954 Phe [F]/Ser [S] −6.2 No effect 0.01 No effect 0 No effect
rs374342938 Gly [G]/Ala [A] 0 No effect 0 No effect 0 No effect
rs769037887 Val [V]/Met [M] −0.3 No effect 0.04 No effect 0 No effect
rs556023421 Phe [F]/Leu [L] −0.4 No effect 0.01 No effect 0 No effect
rs5397 Leu [L]/Val [V] 0.9 No effect 0 No effect 0 No effect
rs5398 Phe [F]/Leu [L] −4.5 No effect 0.01 No effect 0 No effect
rs757137603 Thr [T]/Ile [I] 19.1 No effect 0 No effect 0 No effect
rs1441249949 Phe [F]/ Ile [I] −2.8 No effect 0.01 No effect 0 No effect
rs1195253424 Val [V]/Ile [I] 0 No effect 0 No effect 0 No effect
rs753575081 Pro [P]/Thr [T] 0 No effect 0 No effect 0 No effect
rs777806589 Lys [K]/Arg [R] 0 No effect 0.07 No effect 0 No effect
rs766600474 Ser [S]/Thr [T] 0 No effect 27.03 No effect 0 No effect
rs766600474 Ser [S]/Ala [A] 0 No effect 151.16 Increases 0 No effect
rs1379944645 Glu [E]/Lys [K] −1.9 No effect −13.73 No effect 0 No effect
rs1353603250 Glu [E]/Gln [Q] −1.9 No effect −13.48 No effect 0 No effect
rs1446857276 Glu [E]/Asp [D] 0 No effect −14.56 No effect 0 No effect
rs1283734332 Ile [I]/Thr [T] 0 No effect −14.46 No effect 0 No effect
rs1445660295 Ala [A]/Val [V] 0 No effect 16.65 No effect 0 No effect
rs201797691 Ala [A]/Thr [T] 0 No effect 0.17 No effect 0 No effect
rs201797691 Ala [A]/Pro [P] 0 No effect 0.21 No effect 0 No effect
rs200160167 Ala [A]/Glu [E] 1.7 No effect −0.33 No effect 0 No effect
rs200160167 Ala [A]/Val [V] 0 No effect 31.4 No effect 0 No effect
rs762305192 Phe [F]/Leu [L] 0 No effect −2.56 No effect 0 No effect
rs776826621 Lys [K]/Asn [N] −0.2 No effect 0.23 No effect 0 No effect
rs5399 Lys [K]/Asn [N] −0.2 No effect 0.05 No effect 0 No effect
rs1412427073 Gly [G]/Ser [S] 0 No effect 0.01 No effect 0 No effect
rs966895511 Ala [A]/Ser [S] 0 No effect 0 No effect 0 No effect
rs1199349184 Ala [A]/Val [V] 0 No effect 0 No effect 0 No effect
rs374630641 Arg [R]/Ser [S] −0.2 No effect 0.03 No effect 0 No effect
rs771586150 Pro [P]/Gln [Q] 0 No effect 0 No effect 0 No effect
rs776597156 Lys[K]/Asn[N] −0.2 No effect 0.03 No effect 0 No effect
rs770462591 Ala [A]/Asp [D] 3 No effect −0.72 No effect 0 No effect
rs770462591 Ala [A]/Val [V] 8.5 No effect 0 No effect 0 No effect
rs141574520 Phe [F]/Tyr [Y] −2.7 No effect 0.06 No effect 0 No effect
rs147959014 Gly [G]/Glu [E] 2.8 No effect −0.72 No effect 0 No effect
rs752687355 Glu[E]/Gly[G] −4.4 No effect 0.76 No effect 0 No effect
rs781215842 Thr [T]/Ser [S] 0 No effect 0 No effect 0 No effect
rs758607933 Val[V]/Met[M] 0 No effect 0 No effect 0 No effect

Variations with dTANGO, dWALTZ and dLIMBO between −50 and 50 were supposed to have no effect on aggregation tendency, amyloid propensity and chaperone binding tendency, respectively.

4

4 Discussion

For most living cells, glucose is a vital energy source and an important substrate for biochemical reaction. There are two types of glucose transporters. GLUTs and SGLTs. SGLT family members consist of 580–718 amino acids and 60–80-kDa weight. GLUTs are proteins containing 12 membrane-spanning regions with intracellularl carboxyl and amino terminals. The sequence of GLUT proteins has been known to show 28–65% resemblance with GLUT1. The GLUTs symport glucose by facilitated diffusion mechanism across the plasma membrane (Navale and Paranjape, 2016). On the basis of phylogenetic relationship, 14 human GLUT proteins are grouped into three classes. Class I includes GLUT 1–4 and 14, in class II has GLUT 5,9,7, 11 and class III contains GLUT 6,13,8,12,10 (Manolescu et al., 2007). GLUT2 is a low affinity glucose transporter with affinity of Km of ∼ 17 mM, fructose (∼76 mM), galactose (∼92 mM) and mannose (∼125 mM) but high affinity glucosamine transporter (Km= ∼0.8 mM). The amino acid sequence of GLUT2 shows 81% resemblance among the human, rat and mouse.

In this study, a phylogenetic tree of 10 species of hominidae family including human was constructed using NCBI and Clustal Omega. Evolutionary tree shows that human GLUT2 is most closely related to that of Pongo abelli whereas is least related to GLUT2 of Bos Taurus among these ten members (Fig. 2). GLUT2 was predicted to have 12 transmembrane helices with intracellular amino and carboxyl termini in cytosol. It was also found to contain extracellular and intracellular loops which are located between the segments of 1st and 2nd transmembrane domains and between 6th and 7th transmembrane segments (Fig. 3)

The human genome consists of three billion base pairs. The SNPs neither cause disease nor indicate the sign of disease progression, but they can facilitate to establish the possibility that someone has acquired a specific disease. The SNPs build up approximately 90 % of all genetic variations of human and take place every 100–300 bases on the genome (Noreen and Arshad, 2015). On a large scale genotyping and genome sequencing projects are producing huge data for the sequencing of diseased and healthy individuals. In human beings as well as in the model organisms the sequence variants are present in the genome of protein non-coding and coding regions. In non-coding regions, variants usually have no effect on gene expression and a regular function (Noreen et al., 2021). Association of molecular epidemiological studies is mainly concerned with non synonymous single nucleotide polymorphism (nsSNPs) that resides in exonic regions of gene (Savas et al., 2004; Zhu et al., 2004). Studying the structural as well as functional effect of nsSNPs on protein can facilitate in chosing nsSNPs which are functionally important. The activity and functioning of proteins are affected mainly by the coding variants in which truncation or frame shift, insertion or amino acids deletion or switching are included. There are so many variants, thus it is matter of great challenge to recognize important variants for disease. More than a dozen algorithms have been developed for resolving this issue. Some recent predicted algorithms are developed which utilize some score approaches that are alignment focused such as PolyPhen (Adzhubei et al., 2010), SIFT etc. In this study some sequences as well as structural homology focused algorithms were used to screen those SNPs which can play fundamental role in structural and functional changes in GLUT2.

The SIFT is a tool that was used to predict tolerant and intolerant amino acid substitution effect on protein function (Ng and Henikoff, 2001). It mainly considers homologous sequence alignment and physical amino acid properties to forecast possible influence of nsSNPs on protein. Out of 293 nsSNPs, 167 were forecasted to be damaging (Table 2). PolyPhen-2 (Adzhubei et al., 2010) was used to predict structural and functional influence of the nsSNPs lying in GLUT2. It considers homologous sequences and 3D structures of protein to predict the possible potential effect of SNPs on protein. Out of 293 nsSNPs, 165 were considered to be benign. 65 were predicted to be possibly damaging and 77 were considered to be probably damaging as shown in Table 2.

PROVEAN gave score to forecast neutral and deleterious effect of 293 nsSNPs present in coding region of GLUT2 protein. If the score was equal to or below −2.5 the results were deleterious and if the score was above −2.5, it was neutral. Out of 293 nsSNPs, 162 were considered to be neutral and 138 were predicted to be deleterious. It also gave the results of inframe deletion and insertion. Out of 4 inframe deletion 2 (rs772999215), (rs774721090) were found to be deleterious while others have shown no results. 3 SNPs were inframe insertion (rs1161394690), (rs1463507753), (rs749789723) and no results were found for them (Table 2).

The SNPeffect server was used to predict the effect of molecular phenotype of nsSNPs present in coding region of GLUT2. To find the effect of 293 nsSNPs on aggregation tendency, amyloid propensity and chaperon binding tendency, the dTANGO, dWALTZ and dLIMBO score was obtained. In a protein sequence, aggregation propensity was detected by dTANGO. Out of 293 nsSNPs, 61 were predicted to decrease and 27 to increase the aggregation propensity while 211 had not affect. Amyloid propensity was given by dWALTZ. 23 were expected to increase the amyloid propensity, 16 to decrease the amyloid propensity and 257 had not affect. According to dLIMBO, the chaperon binding tendency was given. None of the nsSNPs had any affecte on chaperon binding tendency (Table 3).

The recessive autosomal disease characterized by acquisition of hepatorenal glycogen, Fanconi nephropathy, galactose and improper carbohydrate utilization is FBS (Fanconi, 1949). Santer et al firstly recognized the underlying defect and GLUT2 as a possible site for the central defect, and three mutations in the GLUT2 gene have been investigated in this concern. At neucleotide 1405, the C /T transition was reported to result in production of truncated GLUT-2 protein leading to development to FBS. (Santer et al., 1997). Our rsults are in line with this study because same nsSNP is predicted to be intolerant, probably damaging and deleterious by SIFT, PolyPhen and PROVEAN respectively.

In human SLC2A2 several SNPs have been described: that are situated at the coding region rs7637863 Pro[P]/Leu[L] at position 68 and rs5400 Thr[T]/Ile[I] at 110 position. The connection of these SNPs with type 2 diabetes is contentious (Barroso et al., 2003). Since then, this “historical” GLUT2 SNP has been analyzed in several genetic studies, and incompatible conclusions were reached: the SNP Thr[T]/Ile[I] at 110 position was showed either related (Barroso et al., 2003; Burgdorf et al., 2011) or not related (Miller et al., 2001😉 with a risk of type 2 diabetes. Other study finds out that, rs5400 was related with the alteration from impaired glucose tolerance to hypercholesterolemia and type 2 diabetes (Laukkanen et al., 2005). During an OGTT performed on subjects stratified according to rs5400 genotype, no variation was shown in insulin secretion (Burgdorf et al., 2011), indicates that neither insulin content nor β cell mass are affected. (Laukkanen et al., 2005). In our study rs5400 was predicted to be tolerant, benign, neutral and responsible for increased aggregation tendency by SIFT, PolyPhen, PROVEAN and dTANGO respectively. Interestingly, this GLUT2 variant was related with high sugar consumption (Eny et al., 2008), indicating a GLUT2 arbitrate mechanism of glucose sensing that could modulate intake of food and sugar preference and consequently be associated with type 2 diabetes mellitus (Mueckler, 1994).

The rs7637863 Pro[P]/Leu[L] at position 68 GLUT2 SNP transported less sugar per unit of transporter, but this characteristic did not support any homeostatic disturbance, at any rate in the physiological situation. The outcome of this study showed that no affect occurs but only SIFT predicted it to be intolerant. Mostly the SLC2A2 gene mutations associated with FBS have been examined by DNA screening. The resulting GLUT2 mutants show transport function loss although biosynthesis of protein and targeting plasma membrane that is similar to wild-type protein for both of them. The syndrome of the patients having these mutations can consequently be recognized as lack of GLUT2 transport activity. Recently, compound heterozygous SLC2A2 mutations characterized by a deletion p.153–4delLI related with a missense mutation rs121909744 Pro[P]/Arg[R] at position 417 has been associated with mild FBS (mild glucosuria) (Grünert et al., 2012). Here, they showed that substitution of leucine Pro[P]/Leu[L] at position 417 diminished transport activity (Yang and Li, 2011). SIFT, PolyPhen and PROVEAN predicted (rs121909744) to have an influence on protein structure and function but SNPeffect showed no affect. Three algorithm (SIFT, PolyPhen and PROVEAN) predicted 101 SNPs to be damaging. Our results seem helpful to those epidemiologists who are involved in large-scale population-based studies. Moreover, on basis of our in silico predictions, actual role of nsSNPs can be assured by conducting demarcated in vitro and in vivo studies.

Acknowledgement

The authors would like to thank the Research Supporting Project number (RSP-2021/97) at King Saud University for funding this study, Riyadh, Saudi Arabia.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  1. , , , , , , , . A method and server for predicting damaging missense mutations. Nat. Methods. 2010;7(4):248.
    [Google Scholar]
  2. , , . Importance of maternal history of non-insulin dependent diabetic patients. Br. Med. J.. 1991;302(6786):1178-1180.
    [Google Scholar]
  3. , , , , , , , , . Evidence from glut2-null mice that glucose is a critical physiological regulator of feeding. Diabetes. 2006;55(4):988-995.
    [Google Scholar]
  4. , , , , , , , . Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet.. 2011;12(11):745-755.
    [Google Scholar]
  5. , , , , , , , . Candidate gene association study in type 2 diabetes indicates a role for genes involved in β-cell function as well as insulin action. PLoS Biol.. 2003;1(1):e20
    [Google Scholar]
  6. , , , , . Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor. Diabetes. 2001;50(8):1720-1728.
    [Google Scholar]
  7. , , , , , , , , . Positive emotional learning is regulated in the medial prefrontal cortex by GluN2B-containing NMDA receptors. Neuroscience. 2011;192:515-523.
    [Google Scholar]
  8. , , , , . Milk synthetic response of the bovine mammary gland to an increase in the local concentration of arterial glucose. J. Dairy Sci.. 2002;85(3):494-503.
    [Google Scholar]
  9. , , , , , . Predicting the functional effect of amino acid substitutions and indels. PLoS ONE. 2012;7(10):e46688
    [Google Scholar]
  10. , , , , , , , , . SNPeffect 4.0: on-line prediction of molecular and structural effects of protein-coding variants. Nucl. Acids Res.. 2012;40(D1):D935-D939.
    [Google Scholar]
  11. Deshpande, N., Addess, K.J., Bluhm, W.F., Merinoott, J.C., Townsend-Merino, W., ZHANG, Q., Knezevich, C., Xie, L., Chen, L., Feng, Z., Green, R.K., Flippen-Anderson, J.L., Westbrook, J., Berman, H.M. and Bourne, P.E., 2005. The RCSB Protein Data Bank: a redesigned query system and relational database based on the mmCIF schema. Nucl. Acids Res., 33: D233-237.
  12. Eny, K. M., Wolever, T. M., Fontaine-Bisson, B., & El-Sohemy, A. (2008). Genetic variant in the glucose transporter type 2 is associated with higher intakes of sugars in two distinct populations. Physiological genomics, 33(3), 355-360.
  13. , . Chronic amino aciduria (amino acid diabetes or nephrotic-glucosuric dwarfism) in glycogenosis and cystine disease. Helv Pediat Acta.. 1949;4:359-396.
    [Google Scholar]
  14. , , , , . Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol.. 2004;22(10):1302-1306.
    [Google Scholar]
  15. , , , , , , , . Differential subcellular distribution of glucose transporters GLUT1–6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. J. Cell. Physiol.. 2006;207(3):614-627.
    [Google Scholar]
  16. , , , , , . Fanconi-Bickel syndrome: GLUT2 mutations associated with a mild phenotype. Mol. Genet. Metab.. 2012;105(3):433-437.
    [Google Scholar]
  17. , , , , , , , , , . Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat. Genet.. 1997;17(3):327-330.
    [Google Scholar]
  18. , , , , , . Detection of human papillomavirus-16 DNA in archived clinical samples of breast and lung cancer patients from North Pakistan. J. Cancer Res. Clin. Oncol.. 2016;142(12):2497-2502.
    [Google Scholar]
  19. , , . The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members. Mol. Membr. Biol.. 2001;18(4):247-256.
    [Google Scholar]
  20. , , , , , , , . Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am. J. Physiol.-Endocrinol. Metabol.. 2002;282(4):E974-E976.
    [Google Scholar]
  21. Kellett, G. L., & Brot-Laroche, E. (2005). Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes, 54(10), 3056-3062.
  22. , , , , . Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol.. 2001;305(3):567-580.
    [Google Scholar]
  23. Laukkanen, O., Lindström, J., Eriksson, J., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., and Laakso, M. (2005). Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes, 54(7), 2256-2260.
  24. , , , , , . Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett.. 2008;582(2):359-364.
    [Google Scholar]
  25. , , , , , . Facilitated hexose transporters: new perspectives on form and function. Physiology. 2007;22(4):234-240.
    [Google Scholar]
  26. , , , , . Polymorphisms of GLUT2 and GLUT4 genes: use in evaluation of genetic susceptibility to NIDDM in blacks. Diabetes. 1990;39(12):1534-1542.
    [Google Scholar]
  27. , , , , , , , , , , , , . Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat. Methods. 2010;7(3):237-242.
    [Google Scholar]
  28. , , , , , . Identification of glucokinase as an alloxan-sensitive glucose sensor of the pancreatic β-cell. Diabetes. 1986;35(10):1163-1173.
    [Google Scholar]
  29. , , , , , , . Hypoglycemia in patients with type 2 diabetes mellitus. Arch. Intern. Med.. 2001;161(13):1653-1659.
    [Google Scholar]
  30. , . Facilitative glucose transporters. Eur. J. Biochem.. 1994;219(3):713-725.
    [Google Scholar]
  31. , , . Glucose transporters: physiological and pathological roles. Biophys. Rev.. 2016;8(1):5-9.
    [Google Scholar]
  32. Ng, P. C., and Henikoff, S. (2001). Predicting deleterious amino acid substitutions. Genome Res., 11(5): 863-874.
  33. , , , . In Silico Analysis of SNPs in Coding Region of Human c-Myc Gene. Pakistan J. Zool.. 2015;47(5)
    [Google Scholar]
  34. , , . Association of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility. Immunol. Res.. 2015;62(2):234-252.
    [Google Scholar]
  35. , , , , , . Knowledge and awareness about breast cancer and its early symptoms among medical and non-medical students of Southern Punjab, Pakistan. Asian Pacific J. Cancer Prevent. APJCP. 2015;16(3):979-984.
    [Google Scholar]
  36. Noreen, M., M. A. Shah, S. M. Mall, S. Choudhary, T. Hussain, I. Ahmed, S. F. Jalil & M. I. Raza (2012) TLR4 polymorphisms and disease susceptibility. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 61, 177-88.
  37. Noreen, M., Muhammad Imran, Sher Zaman Safi, Muhammad Amjad Bashir, Sana Gul, Afrah Fahad Alkhuriji, Suliman Yousef Aloma, Hanan Mualla Alharbi, Muhammad Arshad, Protective role of TIRAP functional variant against development of coronary artery disease, Saudi Journal of Biological Sciences, 2021.
  38. Persson, B., and Argos, P. (1994). Prediction of transmembrane segments in proteins utilising multiple sequence alignments.
  39. , , , , , . Biological and chemical approaches to diseases of proteostasis deficiency. Annu. Rev. Biochem.. 2009;78(1):959-991.
    [Google Scholar]
  40. , , , . Topology prediction for helical transmembrane proteins at 86% accuracy–Topology prediction at 86% accuracy. Protein Sci.. 1996;5(8):1704-1718.
    [Google Scholar]
  41. , , , , , , . Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nat. Genet.. 1997;17(3):324.
    [Google Scholar]
  42. , , , , , . Fanconi-Bickel syndrome–the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature. Eur. J. Pediatr.. 1998;157(10):783-797.
    [Google Scholar]
  43. , , , , , . Identifying functional genetic variants in DNA repair pathway using protein conservation analysis. Cancer Epidemiol. Biomark. Prev.. 2004;13:801-807.
    [Google Scholar]
  44. , , , , . Glucose sensing in pancreatic β-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes. 2001;50(1):1-11.
    [Google Scholar]
  45. Schymkowitz, J., Borg, J., Stricher, F., Nys, R., Rousseau, F. and Serrano, L., 2005. The FoldX web server: an online force field. Nucl. Acids Res., 33: W382-388.
  46. , , , . June). A hidden Markov model for predicting transmembrane helices in protein sequences. Ismb. 1998;6:175-182.
    [Google Scholar]
  47. Tennessen, J. A., Bigham, A. W., O’Connor, T. D., Fu, W., Kenny, E. E., Gravel, S., and NHLBI Exome Sequencing Project. (2012). Evolution and functional impact of rare coding variation from deep sequencing of human exomes. science, 337(6090), 64-69.
  48. , , . Glucose transporters in the 21st Century. Am. J. Physiol.-Endocrinol. Metabol.. 2010;298(2):E141-E145.
    [Google Scholar]
  49. , , , , . Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and β-pancreatic islet cells. Cell. 1988;55(2):281-290.
    [Google Scholar]
  50. , , . Principles governing amino acid composition of integral membrane proteins: application to topology prediction. J. Mol. Biol.. 1998;283(2):489-506.
    [Google Scholar]
  51. Tusnady, G. E., and Simon, I. (2001). The HMMTOP transmembrane topology prediction server. Bioinformatics, 17(9), 849-850..
  52. , , , , , , . Accurate prediction of DnaK-peptide binding via homology modelling and experimental data. PLoS Comput. Biol.. 2009;5(8):e1000475
    [Google Scholar]
  53. , , , . Intestinal absorption in health and disease—sugars. Best Pract. Res. Clin. Gastroenterol.. 2003;17(6):943-956.
    [Google Scholar]
  54. , . Renal Na(+)–glucose cotransporters. Am. J. Physiol. Renal Physiol.. 2001;280(1):F10-F18.
    [Google Scholar]
  55. , , . miRDeep-P: a computational tool for analyzing the microRNA transcriptome in plants. Bioinformatics. 2011;27(18):2614-2615.
    [Google Scholar]
  56. Zhu, Y., Spitz, M.R., Amos, C.I., Lin, J., Schabath, M.B. and WU, X., 2004. An evolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology. Cancer Res., 64: 2251- 2257.

Appendix A

Supplementary data

Supplementary data to this article can be found online at https://doi.org/10.1016/j.jksus.2021.101529.

Appendix A

Supplementary data

The following are the Supplementary data to this article:

Supplementary data 1

Show Sections